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Deficits within the brain microcirculation contribute to poor patient outcome 
following aneurysmal subarachnoid hemorrhage (SAH). However, the underlying 
pathophysiology is not well understood.  Intra-cerebral (parenchymal) arterioles are 
encased by specialized glial processes, called astrocyte endfeet.  Ca2+ signals in the 
endfeet, driven by the ongoing pattern of neuronal activity, regulate parenchymal 
arteriolar diameter and thereby influence local cerebral blood flow.  In the healthy brain, 
this phenomenon, called neurovascular coupling (NVC), matches focal increases in 
neuronal activity with local arteriolar dilation.  This ensures adequate delivery of oxygen 
and other nutrients to areas of the brain with increased metabolic demand.  Recently, we 
demonstrated inversion of NVC from vasodilation to vasoconstriction in brain slices 
obtained from SAH model animals.  This pathological change, which would restrict 
blood flow to active brain regions, was accompanied by an increase in the amplitude of 
spontaneous Ca2+ events in astrocyte endfeet.  It is possible that the emergence of higher 
amplitude endfoot Ca2+ events shifts the polarity of NVC after SAH by elevating levels 
of vasoactive agents (e.g. K+ ions) within the perivascular space. In the first aim of this 
dissertation we tested whether altered endfoot Ca2+ signaling underlies the inversion of 
NVC after SAH.   
Brain injury is often associated with increased levels of extracellular purine 
nucleotides (e.g. ATP).  A recent study found that ATP levels in the cerebrospinal fluid 
of aneurysmal SAH patients were roughly 400-fold higher than that of non-SAH controls.  
Astrocytes express a variety of purinergic (P2) receptors that, when activated, could 
trigger a spike in intra-cellular Ca2+.  It is possible that enhanced signaling via astrocyte 
P2 receptors underlies the change in endfoot Ca2+ signaling after SAH.   In the second 
aim of this dissertation we determined the role of purinergic signaling in the generation 
of high-amplitude spontaneous endfoot Ca2+ events after SAH. 
Parenchymal arteriolar diameter and endfoot Ca2+ dynamics were recorded 
simultaneously in fluo-4-loaded rat brain slices using combined infrared-differential 
interference contrast and multi-photon fluorescence microscopy.  We report that SAH led 
to a time-dependent emergence of spontaneous endfoot high-amplitude Ca2+ signals 
(eHACSs) that were only present in brain slices exhibiting inversion of NVC.  Depletion 
of intracellular Ca2+ stores abolished spontaneous endfoot Ca2+ signals, including 
eHACSs, and restored arteriolar dilation in SAH brain slices to two downstream elements 
in the NVC signaling cascade, (1) increased endfoot Ca2+ and (2) elevated extracellular 
K+.  We next tested the role of purinergic signaling in the generation of SAH-induced 
eHACSs by recording endfoot activity before and after treatment with the broad-
spectrum purinergic receptor antagonist, suramin.  Remarkably, suramin selectively 
abolished eHACSs and restored vasodilatory NVC in SAH brain slices.  Desensitization 
of Ca2+-permeable ionotropic purinergic (P2X) receptors had no effect on eHACSs after 
SAH.  However, eHACSs were selectively blocked using a cocktail of inhibitors 
targeting Gq-coupled purinergic (P2Y) receptors.  Collectively, our results support a 
model in which SAH leads to an emergence of P2Y receptor-mediated eHACSs that 
cause inversion of NVC.   Further, we identify the FDA-approved drug, suramin, as a 
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Chapter 1: Comprehensive Literature Review 
Cerebral Blood Flow  
Anatomy of the Cerebral Vasculature 
 Given its high metabolic demand and extremely limited energy reserves, the brain 
is one of the most highly perfused organs in the body.  It is continually supplied with 
oxygen and nutrients by a dense network of capillaries and micro-vessels which, in 
humans, total about 400 miles in length (Begley and Brightman, 2003).  In order to reach 
these rich capillary beds, oxygenated-blood from the heart is first pumped into the brain 
via two pairs of large arteries: the left and right internal carotid arteries, and the left and 
right vertebral arteries.  The former diverge to become the left and right middle cerebral 
arteries (MCAs) and anterior cerebral arteries (ACA), respectively, whereas the latter 
converge on the surface of the pons to form the basilar artery.  The vertebral-basilar 
system feeds the brainstem, cerebellum and posterior portions of the cerebrum.  
Collectively, the vertebral-basilar network comprises the posterior circulation of the 
brain, whereas the left and right MCAs and ACAs comprise the anterior circulation and 
supply the remaining neural tissue.  Although blood flow between the anterior and 
posterior circulations is normally kept separate, there is a large anastomosis called the 
Circle of Willis located at the ventral surface of the brain which physically links the two 
networks. 
 There are some important differences between the arteries coursing over the brain 
surface and their penetrating branches that feed the underlying neurons.  Firstly, the walls 
of brain surface (pial) arteries are comprised of multiple layers of circumferentially-
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oriented vascular smooth muscle cells (Cipolla 2009).  Even the smallest pial arteries and 
arterioles have from 2-3 layers of vascular smooth muscle.  In contrast,  penetrating and 
parenchymal arterioles have just a single layer of vascular smooth muscle.  Another 
important contrast is that the walls of pial arteries and arterioles are innervated 
extrinsically by the peripheral nervous system (Baeres and Moller 2004; Hamel 2006).  
This innervation is lost as the brain-penetrating branches become parenchymal arterioles 
deep to the Virchow-Robin space (Cipolla et al., 2004; Cipolla 2009).  Accordingly, the 
responsiveness of MCA-derived parenchymal arterioles to neurotransmitters such as 
serotonin and noradrenaline is significantly blunted when compared to the effects of these 
transmitters directly on the MCA (Cipolla et al., 2004).  Perhaps the most profound 
distinction between pial and parenchymal arterioles is the near complete investment of 
parenchymal arterioles by astrocyte endfeet (McCaslin et al., 2011).  The endfoot sheath 
surrounding parenchymal arterioles plays a very important role in regulating arteriolar 
diameter and thus, local cerebral blood flow (Filosa et al., 2015; Kim et al., 2015). 
Mechanisms Regulating Cerebral Blood Flow 
 Continuous perfusion of the brain is essential for the maintenance of neuronal 
homeostasis and function.  Two key mechanisms are in place to ensure that the brain 
remains adequately perfused under a variety of conditions: cerebral auto-regulation and 
neurovascular coupling (also known as functional hyperemia).  Cerebral auto-regulation 
refers to the intrinsic property of the arterial wall to maintain constant blood flow by 
responding to increases and decreases in intraluminal pressure by constricting and 
dilating, respectively.  This remarkable property, called myogenic tone, was first 
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described over a hundred years ago by the English physiologist, William Bayliss 
(Bayliss, 1902), and the mechanisms by which this occurs in the brain have only recently 
begun to be elucidated.   Currently, the prevailing theory is that pressure-induced stretch 
activates G-coupled purinergic receptors (in the case of parenchymal arterioles) on the 
smooth muscle membrane leading to Na+ influx via transient receptor potential melastatin 
4 (TRPM4) channels (Brayden et al., 2013; Li et al., 2014).  The activation of TRPM4 
causes smooth muscle depolarization, Ca2+ influx through voltage-dependent Ca2+ 
channels (VDCCs) and activation of the contractile apparatus.  This cerebral auto-
regulatory mechanism ensures constant blood flow over a range of physiologic pressures 
and also serves to protect downstream capillaries from drastic changes in blood flow 
which would occur in the absence of myogenic tone. 
      Aside from cerebral auto-regulation, the brain possesses the unique ability to 
redirect blood flow according to ongoing changes in neuronal metabolic demand.  
Interestingly, this process, called neurovascular coupling, was first noted by Roy and 
Sherrington (1890) well before the auto-regulatory phenomenon had been observed.  In 
their classic study, Roy and Sherrington (1890) measured volume expansion of the canine 
brain during peripheral nerve stimulation, and reported that brief stimulation of the sciatic 
nerve reliably evoked an immediate increase in cerebral volume.  This transient 
expansion of the brain paralleled a rise in arterial pressure suggesting that increased 
neuronal activity was tightly coupled to increased cerebral blood flow.  Notably, the 
evoked cerebral volume expansion was observed under a variety of conditions including 
stimulation of the medulla oblongata and spinal cord.  It was even evident during 
volitional movement of the lightly anesthetized animal.  Although this rudimentary study 
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was unable to address the mechanistic pathway involved, it succeeded in advancing the 
notion that neuronal activity and cerebral blood flow are functionally linked.  
Importantly, this study helped lay the groundwork for a concept (i.e. neurovascular 
coupling) which would later form the basis of functional magnetic resonance imaging 
(fMRI). 
Astrocytes and their Relationship to Intra-Cerebral Blood Vessels 
Investment of local synapses as well as the intra-cerebral vasculature by cortical 
astrocytes was first described over a century ago by the renowned neuroanatomist, 
Santiago Ramon y Cajal (Navaerrete and Araque, 2014).  This structural arrangement 
between astrocyte endfeet and nearby blood vessels has since been confirmed using more 
conventional methods, such as transmission electron microscopy and in vivo multi-
photon imaging (Mathiisen et al., 2010; McCaslen et al., 2011).  Interestingly, early 
analyses of astrocyte biophysical properties suggested that the functional significance of 
this arrangement served to protect neuronal elements by shunting the increase in 
extracellular K+ ions that accompanies enhanced synaptic transmission to distant areas 
with lower K+ levels (Trachtenburg and Pollen, 1970).  Later work by Newman (1984) 
expanded on this theme by demonstrating substantial K+ conductance in astrocyte endfeet 
which could be stimulated by an elevation of extracellular K+ at distal cellular processes.  
Remarkably, the evoked K+ conductance exhibited by the endfeet was roughly 10-fold 
higher than that of the rest of the cell (Newman, 1986).  These observations ultimately 
led the investigators to pose the question of whether the K+ released from astrocyte 
5 
 
endfeet in response to enhanced neurotransmission plays a role in the regulation of local 
cerebral blood flow (Paulson and Newman, 1987).   
Unfortunately, however, this concept was ahead of its time.  Before the matter 
was directly addressed in the study by Filosa et al. (2006) a number of important 
observations were made which helped bolster our understanding of the signaling 
dynamics between neurons and astrocytes.  The first major discovery was that of intra- 
and inter-cellular Ca2+ waves in cultured astrocyte networks exposed to the excitatory 
neurotransmitter, glutamate (Cornell-Bell et al., 1990).  The observation that glutamate 
evoked astrocyte Ca2+ waves that often spread between cells, was the first indication that 
local synaptic activity could elicit long-range signaling in nearby astrocytes.  Importantly, 
this concept was confirmed by subsequent work demonstrating similar Ca2+ elevations in 
hippocampal astrocytes in situ following brief stimulation of the Schaffer collaterals 
(Porter and McCarthy, 1996); the principle excitatory input to the hippocampus.  The 
elevation of astrocyte Ca2+ in these studies was suggested to be due to spillover of 
glutamate from the synaptic cleft activating ionotropic and metabotropic glutamate 
receptors on astrocyte processes.  This possibility was supported by the later work of 
Shelton and McCarthy (1999) who showed that astrocyte Ca2+ elevations could be 
evoked by treating brain slices with the group I/II metabotropic glutamate receptor 
agonist, t-ACPD. 
Astrocyte Involvement in Neurovascular Coupling 
 Considering the anatomical arrangement of astrocytes, with some processes 
enveloping neuronal synapses and others wrapping around the intra-cerebral vasculature 
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(i.e. endfeet), it was only natural to ask whether a link existed between neuronal activity-
evoked astrocyte Ca2+ elevations and the regulation of local cerebral blood flow.  Taking 
advantage of the ex vivo brain slice preparation, which preserves the unique architecture 
of astrocytes, Zonta et al (2002) clearly demonstrated that neuronal stimulation triggered 
astrocyte endfoot Ca2+ elevations which preceded vasodilation of the underlying arteriole.  
Further, consistent with previous studies, treatment of brain slices with a metabotropic 
glutamate receptor antagonist, MPEP, significantly blunted the neurally-evoked endfoot 
Ca2+ elevations as well as arteriolar dilation. Conversely, application of the metabotropic 
glutamate receptor agonist, t-ACPD, triggered a rise in endfoot Ca2+ that preceded 
arteriolar dilation.  Expanding on this work, Winship et al. (2007) confirmed these results 
in vivo by demonstrating rapid, neuronal activity-dependent Ca2+ signals in cortical 
astrocytes which preceded the hyperemic response.  Together, these studies comprised 
the first demonstration of an essential role for astrocyte Ca2+ signaling in linking neuronal 
activity with increased local cerebral blood flow.  However, it should be noted that in the 
decades prior to these studies, the prevailing theory behind neurovascular coupling was 
that direct innervation of the vascular wall contributed to the coordination of local blood 
flow with neuronal function (Reinhard et al., 1979; Vaucher and Hamel, 1995; Krimer et 
al., 1998).  While this theory has lost support over the years, the existence of a neuronal 
component to neurovascular coupling cannot be totally ruled out. 
To this day there is dissention as to the vasoactive factor(s) that are released from 
the endfeet during neurovascular coupling.  Generally speaking, there are 2 major Ca2+-
dependent pathways which could be recruited in the endfeet following neuronal 
activation (Fig. 1).  The first of these pathways, which gained popularity early on, 
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involves Ca2+-dependent cleavage of arachidonic acid (AA) from the endfoot membrane 
by phospholipase A2 (PLA2) (Koehler et al, 2009).  Early work using primary cultures of 
astrocytes obtained from 3-day-old rat pups showed that exposure to glutamate mobilized 
AA and resulted in the release of one of its metabolites, epoxyeicostrienoic acids (EETS) 
(Alkayed et al., 1997).  EETs are potent dilators of brain surface arteries and exert their 
effect by enhancing K+ efflux from vascular smooth muscle cells (Gebremedhin et al., 
1992).  Formation of EETs from AA requires the action  of cytochrome P-450 (P-450) 
2C11, an enzyme which has been shown to be expressed by cortical astrocytes (Alkayed 
et al., 1996).  Interestingly, treatment of pial arteries with another AA metabolite, 20-
hydroxyeicosatetraenoic acid (20-HETE), caused vasoconstriction by inhibiting smooth 
muscle K+ channel activity (Harder et al., 1994).  Contrary to EETs, the generation of 20-
HETE from AA occurs via the action of P-450 4-A.  Harder et al (1994) demonstrated 
functional expression of P-450 4-A in cerebral vascular smooth muscle cells isolated 
from cats.   In a perplexing, yet high-profile study by Mulligan and MacVicar (2004), 
elevation of astrocyte endfoot Ca2 by photolysis of caged-Ca2+ (uncaging) caused 
vasoconstriction of the underlying blood vessel.  Based on their pharmacologic approach, 
the investigators concluded that the endfoot Ca2+ elevation activated Ca2+-sensitive PLA2 
leading to the release of AA from the endfoot membrane.  According to their model, the 
liberated AA then diffused across the perivascular space entering the vascular wall where 
it was metabolized into the vasoconstrictor, 20-HETE, by P-450 4-A.  It is important here 
to mention that the brain slices used in these studies were not pretreated with a 
vasoconstrictive agent.  Thus, as the vasculature in their preparation was unpressurized, it 
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is likely that the vessels were maximally dilated at baseline.  This complicates things, as 
the only response that could be measured, based on their conditions, is vasoconstriction. 
There is yet a third class of vasoactive AA metabolites which has been suggested 
to play a role in neurovascular coupling; the prostaglandins (Haydon and Carmignoto 
2006).  In a study by Zonta et al (2003) it was discovered that the glutamate-induced 
elevation of intracellular Ca2+ elevation led to the release of prostaglandin E2 (PGE2) 
from astrocytes in vitro.  Astrocytes express the cyclooxygenase-2 (COX-2) enzyme 
which is responsible for the conversion of AA to PGE2 (Hirst et al., 1999).  Interestingly, 
despite the attention and recognition PGE2 has received for its alleged vasodilatory 
influence during neurovascular coupling (Attwell et al., 2010), recent work demonstrated 
that PGE2 actually constricts parenchymal arterioles isolated from the rodent brain 
(Dabertrand et al., 2013).  This would argue against the involvement of astrocyte-derived 
PGE2 in linking neuronal activity to increased local cerebral blood flow.   
Given the confounding results and complex mechanism(s) by which astrocyte-
derived AA is thought to impact the local intra-cerebral vasculature during neurovascular 
coupling, it is difficult to reconcile this pathway with the rapid and highly reproducible 
vasodilatory responses exhibited by parenchymal arterioles in vivo (Winship et al., 2007). 
The second Ca2+-dependent pathway which could be recruited into neurovascular 
coupling brings us back to the original proposition by Paulson and Newman (1987).  That 
is, astrocyte-mediated K+ release establishes the link between increased neuronal activity 
and enhanced local cerebral blood flow.  Cerebral arteries are extremely sensitive to 
changes in the extracellular K+ concentration.  Modest increases in extracellular K+ (≤ 20 
mM) dilate cerebral arteries and parenchymal arterioles by activating inward rectifier K+ 
9 
 
(Kir) channels on vascular smooth muscle (Knot et al., 1996; Zaritsky et al., 2000; Filosa 
et al., 2006; Girouard et al., 2010).  Conversely, larger increases in extracellular K+ (> 20 
mM) depolarize the smooth muscle membrane leading to enhanced Ca2+ influx through 
VDCCs and vasoconstriction.   Large-conductance Ca2+-activated K+ (BK) channels are 
enriched in the endfoot membrane abutting parenchymal arteriolar smooth muscle (Price 
et al., 2002).  Astrocytes express the β4 subunit which confers profound Ca2+ sensitivity 
to the BK channels (Horrigan and Aldrich, 2002; Bai et al., 2011; Seidel et al., 2011).  As 
parenchymal arteriolar dilation occurs within seconds of an evoked rise in endfoot Ca2+ 
(Takano et al., 2006), Filosa et al. (2006), tested whether endfoot BK channels are 
recruited into the neurovascular coupling signaling cascade.  Using on-cell patch clamp 
electrophysiology, Filosa et al. (2006) clearly demonstrated robust iberiotoxin-sensitive 
BK currents in the endfeet following neuronal activation.  Thus, during neurovascular 
coupling, BK-dependent K+ efflux could conceivably impact blood vessel diameter by 
directly affecting the smooth muscle membrane potential.  This would be consistent with 
the rapid responses of parenchymal arterioles (1-2 second latency) to increased endfoot 
Ca2+ (Takano et al., 2006). 
Elevation of extracellular K+ can cause either dilation or constriction depending 
on the concentration (Knot el al., 1996).  In a clever study demonstrating the duality of 
arteriolar responses to elevated K+, Girouard et al. (2010) showed that evoking a modest 
rise in endfoot Ca2+ (300-400 nM) caused the anticipated vasodilation, whereas evoking 
larger increases in endfoot Ca2+ (> 700 nM) caused vasoconstriction.  Interestingly, 
Girouard et al (2010) also showed that arteriolar constriction could be evoked by raising 
endfoot Ca2+ modestly (300-400 nM) in the presence of artificially elevated extracellular 
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K+.  Importantly, both the evoked dilations and constrictions were abolished in the 
presence of the BK channel blocker, paxilline.  These data not only highlight endfoot-
derived K+ as a key mediator of neurovascular coupling, they also show that polarity of 
the arteriolar response depends on the amount of K+ released (i.e. the amplitude of the 
endfoot Ca2+ transient).  
At present, the pathways involved in neurovascular coupling are still under 
scrutiny.  For example, the identity of the vasoactive agent released from the endfeet 
during neurovascular coupling continues to be debated.  Further, recent advances in 
genetic manipulation techniques (e.g. knock-outs and designer receptors exclusively 
activated by designer drugs [DREADS]) have shaken the field and questioned the role of 
astrocyte Ca2+ signaling in mediating neurovascular coupling (Nizar et al., 2013; Bonder 
and McCarthy, 2014).  Despite these setbacks, however, it seems that even in a mouse 
model in which astrocytes allegedly lack inositol 1,4,5-trisphosphate (IP3) dependent 
Ca2+ signals, both endfoot Ca2+ signaling and neurovascular coupling are retained 
(Srinivasan et al., 2015).  Currently, the field of neurovascular coupling is also even 
beginning to explore the potential role of the vascular endothelium in mediating the 
upstream arteriolar dilation (Chen et al., 2014).  It is possible that endothelial Kir 
channels sense ongoing changes in local K+ and send a hyperpolarizing electrical signal 
through the capillary network to dilate upstream arterioles (Longden and Nelson, 2015).  
Importantly, it is likely that for such a critical phenomenon as neurovascular coupling, 
there will be multiple, redundant pathways to ensure adequate delivery of oxygen-rich 





Definition and Classifications 
 Strokes, often referred to as cerebrovascular accidents, occur following a 
pathological disruption of blood flow to the brain that results in neuronal cell death.  
Broadly, strokes are classified into two subtypes: ischemic and hemorrhagic.  In the case 
of ischemic strokes, blood flow to the brain, or parts of the brain, is disrupted by a 
physical barrier, often a blood clot.  Ischemic strokes are the most common form of 
stroke and recent work has actually demonstrated a reduction in age-standardized 
mortality rates over the past two decades for ischemic stroke patients (Bennett et al., 
2009).  Conversely, hemorrhagic strokes, which include both intra-cerebral hemorrhage 
(ICH) and subarachnoid hemorrhage (SAH), are much less prevalent (~ 10-27% of all 
strokes) yet both have 30-day mortality rates at nearly 50% (Feigin et al., 2009; 
Krishnamurthi et al., 2014).   
Hemorrhagic strokes, as the name implies, involve massive bleeding following 
the rupture of a cerebral blood vessel.  This bleeding can occur within the brain 
parenchyma, in the case of ICH, or within the subarachnoid space, as in SAH. For the 
purposes of this dissertation, we will focus primarily on SAH. 
Aneurysmal Subarachnoid Hemorrhage (SAH) 
 The rupture of a “saccular” cerebral aneurysm, an acquired vascular abnormality 
causing protrusion of the arterial wall, accounts for 80-85% of spontaneous, non-
traumatic SAH strokes (Jakubowski and Kendall, 1978).  Cerebral aneurysms typically 
form at the base of the brain near branch points close to the Circle of Willis (Ajiboye et 
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al., 2015).  The incidence of cerebral aneurysms in adults is estimated between 1-5% 
(Mocco et al., 2004), yet aneurysm rupture is quite rare; affecting only about 30,000 
people annually in the United States (Peters et al., 2001).  Following aneurysmal rupture, 
high-pressure arterial blood is released into the subarachnoid space (i.e. SAH) where it 
can spread over the brain surface.  As mentioned, this form of stroke carries a relatively 
high mortality rate and only about half of long-term survivors regain independence for 
daily life (Passier et al., 2012).   
 A major hurdle affecting survival and functional outcome after aneurysmal SAH 
is the development of delayed cerebral ischemia (DCI) days to weeks after the initial 
bleed (Al-Khindi et al., 2010; Ostergaard et al., 2013).  DCI presents either as cerebral 
infarction within a single territory close to the site of aneurysm rupture, multiple 
independent lesions scattered throughout the brain, or a combination of both (Dreier et 
al., 2002; Rabinstein et al., 2005; Weidauer et al., 2008).  Historically, the prolonged, 
blood-induced constriction of large-diameter pial arteries (i.e. vasospasm) was thought to 
underlie the development of DCI after SAH (Pluta et al., 2009).  This is largely because 
the development of SAH-induced vasospasm, occurring 3-8 days post-stroke, often 
coincides with the onset of DCI (Weir et al., 1978).  However, recent clinical trials using 
the endothelin receptor inhibitor, Clazosentan, have demonstrated effective prevention of 
vasospasm, yet failed to significantly improve patient outcome (Macdonald et al., 2011; 
Macdonald et al., 2012).  Importantly, this indicates that vasospasm is not the sole cause 
of DCI after SAH.  Further, these negative results have redirected the focus of SAH 




Impact of SAH on the Intra-Cerebral Vasculature 
 Currently, the prevailing theory is that a disruption of blood flow within the brain 
parenchyma after SAH contributes to the development of DCI by restricting O2 delivery 
to discrete brain territories.  This idea is attractive; as it is consistent with the fact that 
angiographic vasospasm often fails to predict the pattern of subsequent brain infarction in 
SAH patients (Rabinstein et al., 2005; Weidauer et al., 2008).  Further, the arterial 
networks on the brain surface exhibit substantial anastomoses and redundancy which are 
protective in case of small vessel occlusion (Vander Eecken and Adams, 1953).  In 
contrast, parenchymal arterioles lack such collateral flow (Nishimura et al., 2010).  Each 
arteriole feeds a specific domain within the cortex and there is little overlap in the 
territories supplied by neighboring vessels.  Thus, disruption of blood flow through one 
or more adjacent parenchymal arterioles would be predicted to cause a spatially-defined 
focal infarct, similar to what is observed in the human brain following SAH (Dreier et al., 
2002; Rabinstein et al., 2005; Weidauer et al., 2008).   
The idea that blood flow through distal arterioles (in relation to brain surface 
arteries) is hemodynamically important after SAH is not necessarily new.  Descriptions 
of this concept can be found in early reports of altered cerebral blood flow almost 50 
years ago (Zingesser et al., 1968; Heilbrun et al., 1972).  Heilbrun et al. (1972) even 
suggested that auto-regulatory dysfunction in the small-diameter arterioles could lead to 
focal ischemia after SAH by reducing blood flow beyond some critical threshold.  
Interestingly, more recent work implicates impairment in metabolically-driven changes in 
intra-cerebral blood flow (i.e. functional hyperemia, or neurovascular coupling) in 
aneurysmal SAH patients (Dreier et al., 2009).  In this study, the investigators 
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simultaneously measured brain electrical activity and regional cerebral blood flow using 
direct current-electrocorticography and laser Doppler flowmetry, respectively.  The 
authors found that cortical spreading depolarizations (CSDs), which involve a mass 
neuronal depolarization followed by a quiescent recovery period, were sometimes 
accompanied by a physiologic hemodynamic response (i.e. increased blood flow and 
tissue hyperoxia) or an inverse hemodynamic response (decreased blood flow and tissue 
hypoxia).  Importantly, clusters of prolonged CSDs, which were associated with inverse 
hemodynamic responses, occurred in regions exhibiting neuronal damage.  These data 
indicate a possible link between inverse hemodynamic responses (i.e. neuronal activity-
dependent vasoconstriction) and the development of focal brain injury in patients 
following aneurysmal SAH.       
Animal Models to Understand SAH Pathology 
 Understanding the impact of SAH on intra-cerebral hemodynamics is difficult 
given the technical limitations for human studies.  However, the use of animal models has 
provided a great advantage in our ability to discern the mechanisms leading to vascular 
dysfunction and the development of DCI following SAH.  The breadth of animal models 
ranges from rodents to non-human primates.  For the purposes of this dissertation, we 
will focus primarily on the rat intra-cisternal double injection SAH model.  Although this 
model has been modified from the original (Solomon et al., 1985) by including a second 
SAH induction (usually following a 24-48 hour recovery period), it is frequently used as 
it reliably recapitulates the delayed vasospasm observed in SAH patients (Vatter et al., 
2006).  Briefly, autologous arterial blood is introduced into the subarachnoid space of 
15 
 
anesthetized animals by way of the cisterna magna.  Typically, the animals are then 
allowed to recover for 24 to 48 hours, after which the procedure is repeated.  One 
limitation is that this model does not mimic the arterial wall damage accompanying a 
ruptured aneurysm.  However, it is still preferred over vascular perforation models as the 
blood volume entering the subarachnoid space is under the experimenter’s control.   
 Using experimental models of SAH, such as the ones described above, we now 
know that the presence of subarachnoid blood has a profound impact on parenchymal 
arteriolar function.  Ex vivo studies using animal models of SAH have demonstrated 
enhanced myogenic tone and decreased sensitivity to endothelial-derived vasodilators in 
isolated parenchymal arterioles (Park et al., 2009; Nystoriak et al., 2011).  Given that 
brain parenchymal arterioles account for roughly 40% of the total cerebrovascular 
resistance (Faraci and Heistad, 1990), the enhanced tone in these blood vessels after SAH 
could significantly limit cerebral perfusion on a global scale.  This interpretation would 
be consistent with the early observations by Heilbrun et al. (1972), who noted a decrease 
in global cerebral blood flow in SAH patients even in the absence of angiographic 
vasospasm. 
 It is possible that extravasated blood components, such as oxyhemoglobin, could 
cause enhanced tone after SAH by altering expression of key ion channels on 
parenchymal arteriolar myocytes.  Acute exposure of pial arteries to oxyhemoglobin led 
to enhanced pressure-dependent constriction by suppressing voltage-dependent K+ (Kv) 
channels on vascular smooth muscle (Ishiguro et al., 2006).  Further, culturing pial 
arteries for five days in the presence of the blood component, oxyhemoglobin, resulted in 
functional expression of the R-type VDCC (Link et al., 2008).  Importantly, upregulation 
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of the R-type VDCC contributed to the myogenic tone of these arteries.  Although the 
studies above addressed SAH-induced changes in brain surface arteries, they have helped 
pave the way for elucidating the impact of SAH on parenchymal arterioles.  Accordingly, 
studies have shown that parenchymal arteriolar myocytes isolated from SAH model 
animals exhibit suppression of Kv channels (Koide and Wellman, 2013).  Importantly, Kv 
suppression in parenchymal arterioles appears to involve the same oxyhemoglobin-
mediated endocytic pathway causing Kv suppression in pial artery myocytes (Koide et al., 
2007).  To date, however, it remains to be determined whether parenchymal arteriolar 
myocytes express R-type VDCCs after SAH.   
The above mechanisms, which affect parenchymal arteriolar auto-regulation, 
would be expected to negatively impact blood flow in the brain on a global level by 
increasing the total cerebrovascular resistance.  However, as mentioned previously, blood 
flow through parenchymal arterioles is also regulated extrinsically by surrounding 
astrocyte endfeet in a phenomenon called, neurovascular coupling.  Human studies have 
already provided evidence demonstrating an inverse coupling between neuronal activity 
and local cerebral blood flow after SAH (Dreier et al., 2009).  Importantly, this deficit is 
also present in the rat double injection SAH model.  Recent work demonstrated inversion 
of neurovascular coupling from vasodilation to vasoconstriction in brain slices obtained 
from SAH model animals (Koide et al., 2012).  As mentioned, neurovascular coupling is 
dependent on neurally-evoked elevation of endfoot Ca2+ causing release of vasoactive 
agents (such as K+ ions) into the perivascular space (Straub and Nelson, 2007).  
Importantly, Koide et al. (2012) demonstrated that the opposing vascular responses 
between control and SAH animals (i.e. dilation and constriction) were both abrogated in 
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the presence of the BK channel blocker, paxilline.  This suggests that elevation of 
extracellular K+ mediates both the dilation in control animals and the constriction after 
SAH.  Further, this study demonstrated that the dilation and constriction were retained 
even when endfoot Ca2+ was elevated experimentally by photolysis of caged-Ca2+; a 
technique that bypasses neuronal activation.  This indicates that the inversion of 
neurovascular coupling after SAH reflects abnormal signaling between the astrocyte 
endfeet and underlying parenchymal arterioles.   
The investigators made another interesting observation in this study; an increase 
in the amplitude of spontaneous Ca2+ events in astrocyte endfeet surrounding 
parenchymal arterioles.  Importantly, the increased amplitude of spontaneous Ca2+ events 
after SAH was suggested to cause an abnormal elevation of perivascular K+ that, when 
combined with K+ efflux stimulated by neuronal activity or endfoot Ca2+ uncaging, raised 
perivascular K+ beyond the dilation/constriction threshold (Fig. 2).  This interpretation 
would be consistent with previous work by Girouard et al. (2010) which showed that 
artificially raising the pre-existing K+ concentration resulted in a reversal of 
neurovascular coupling from vasodilation to vasoconstriction in brain slices from healthy 
control animals.  Further, this interpretation is significant because the concept of a 
functional change in astrocytes leading to a vascular deficit after SAH had not been 
previously considered.  Determining the role of spontaneous astrocyte Ca2+ signaling in 
mediating a disturbance in local cerebral blood flow will profoundly impact our 
understanding of the adverse events following SAH.  The first aim of this dissertation is 
to determine whether altered Ca2+ signaling in astrocyte endfeet underlies SAH-induced 




Astrocyte Ca2+ signaling 
Evoked vs Spontaneous Ca2+ Signaling 
 Astrocytes are incapable of firing action potentials, but rather, they signal to 
neighboring cells using a special form of Ca2+ excitability (Verkhratsky et al., 1998).  
Astrocyte Ca2+ signaling can be triggered by a variety of manipulations including: 
exposure to endogenous ligands (e.g. glutamate, histamine, and ATP) (Cornell-Bell et al., 
1990; Kirischuk et al., 1995; Shelton and McCarthy, 2000), electrical stimulation 
(Nedergaard, 1994), and mechanical stretch (Newman and Zahs, 1997).  The 
responsiveness of astrocytes to these environmental signals highlights their role in 
sensing and maintaining CNS homeostasis.   
 Shortly after the discovery that neurotransmitters such as glutamate evoke 
astrocyte Ca2+ elevations (Cornell-Bell et al., 1990), it was discovered that astrocytes in 
culture exhibit spontaneous fluctuations in intra-cellular Ca2+ in the absence of neuronal 
input (Fatatis and Russell, 1992).  This early work sparked considerable interest in 
determining the nature and functional consequences of spontaneous astrocyte Ca2+ 
signaling.  In their now classic study, Parri et al. (2001) first proposed the concept that 
astrocytes not only sense ongoing neurotransmission, but that they can also act as 
generators of neuronal activity through spontaneous fluctuations in intracellular Ca2+.  By 
combining patch clamp electrophysiology with brain slice Ca2+ imaging, the investigators 
demonstrated that asynchronous, spontaneous (i.e. non-stimulated) intra- and inter-
cellular astrocyte Ca2+ waves triggered NMDA receptor-mediated currents in adjacent 
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neurons.  A similar approach by Fiacco and McCarthy (2004) demonstrated astrocyte 
Ca2+ signal-dependent AMPA receptor currents in adjacent neurons.  These thought-
provoking studies sparked a massive interest in linking spontaneous astrocyte Ca2+ 
signaling to neuronal physiology.  As a result, we now know that astrocyte spontaneous 
Ca2+ signaling contributes to synaptic plasticity (Henneberger et al. 2010; Navarrete et 
al., 2012; Chen et al., 2013), neurotransmitter release (Perea and Araque, 2007), and 
network activity (Angulo et al., 2004).  Further, it is likely that the same astrocyte-to-
neuron signaling pathways, which were largely explored in rodent brains, are relevant to 
the human condition.  Using biopsies from human epileptic patients, Navarrete et al. 
(2013) showed convincing evidence that astrocyte Ca2+ signals could increase the 
frequency of NMDA receptor-mediated currents in neighboring cortical or hippocampal 
neurons.   
 While the bulk of the work has examined spontaneous Ca2+ signaling in astrocyte 
somata or perisynaptic processes, it should be noted that astrocyte endfeet also exhibit 
spontaneous Ca2+ events in the absence of neuronal stimulation (Koide et al., 2012; Dunn 
et al., 2013; Shigetomi et al., 2013).  Currently, there is little known about these 
spontaneous endfoot Ca2+ oscillations.  However, it is possible that endfoot Ca2+ 
signaling could influence neurovascular coupling by altering levels of vasoactive 
substances (e.g. K+ ions) within the restricted perivascular space, as was suggested to 
occur following SAH (Koide et al., 2012).   
Ca2+-permeable TRP Vanilloid 4 (TRPV4) channels are functionally expressed on 
astrocyte endfeet (Benfenati et al., 2007).  Dunn et al. (2013) demonstrated that 
pharmacologic activation of endfoot TRPV4 channels resulted in a transient increase in 
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the frequency and amplitude of spontaneous endfoot Ca2+ events in situ.  Interestingly, 
pharmacologic inhibition of endfoot TRPV4 activity abrogated neurovascular coupling 
responses (both endfoot Ca2+ elevation and arteriolar dilation) in situ and in vivo.  These 
data suggest a possible role for endfoot TRPV4 channels during neurovascular coupling 
in healthy control animals.  To determine whether aberrant TRPV4 activity contributed to 
the increased amplitude of spontaneous endfoot Ca2+ events and inversion of 
neurovascular coupling after experimental SAH, Koide and Wellman (2015) recorded 
these phenomena in brain slices obtained from SAH animals before and after treatment 
with a selective TRPV4 inhibitor.  The investigators found no effect of TRPV4 inhibition 
on the altered Ca2+ signals or inverted neurovascular coupling responses after SAH.   
To date, the studies by Dunn et al. (2013) and Koide and Wellman (2015) 
represent the only attempts to elucidate the role of spontaneous endfoot Ca2+ signaling on 
local blood flow regulation in brain cortex.  Thus, determining whether the increased 
amplitude of spontaneous endfoot Ca2+ events drives inversion of neurovascular coupling 
after SAH will not only resolve a potential pathway involved in SAH pathology, it may 
also identify another role for endogenous astrocyte Ca2+ signaling in the brain.    
Origin of Spontaneous Ca2+ Signals in Astrocytes 
Astrocyte Ca2+ signals, whether evoked or spontaneous, are generally appreciated 
to result from the release of Ca2+ from subcellular IP3-dependent ER stores (Cornell-Bell 
et al., 1990; Shao and McCarthy, 1995; Nett et al., 2002; Parri and Crunelli, 2003; Straub 
et al., 2006).  Astrocytes express a multitude of Ca2+-permeable ion channels (e.g. 
TRPV4) and Gq-coupled receptors that, when activated, could trigger Ca2+ release from 
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the ER.  Early studies examining spontaneous astrocyte Ca2+ signaling in the developing 
ventrobasal thalamus attributed a Ca2+-induced Ca2+ release (CICR) pathway involving 
Ca2+ influx through voltage-dependent Ca2+ channels (VDCCs) triggering subsequent 
Ca2+ release through subcellular IP3 receptors (IP3Rs) (Parri et al., 2001; Parri and 
Crunelli, 2003).  However, the expression of VDCCs in astrocytes is controversial.  
Currently, the only evidence for VDCC expression in astrocytes comes from studies 
examining cultured cells (MacVicar, 1984; MacVicar et al., 1991; Latour et al., 2003).  
Aside from the few studies examining astrocytes of the developing thalamus (Parri et al., 
2001; Parri and Crunelli, 2003), there is no evidence of VDCCs in hippocampal or 
cortical astrocytes in situ (Carmignoto et al., 1998).  It is possible that VDCC expression 
in astrocytes is location-specific and/or developmentally regulated.  We learned earlier 
that activation of TRPV4 channels could transiently increase the amplitude and frequency 
of spontaneous endfoot Ca2+ events (Dunn et al., 2013).  This effect was mediated by 
CICR in the endfeet.  However, inhibition of TRPV4 channels did not block the basal 
events suggesting that spontaneous endfoot Ca2+ activity occurs independent of TRPV4 
channels.   
A thorough characterization of the mechanism underlying the generation of 
spontaneous astrocyte Ca2+ signals was provided in an early study by Nett et al. (2002).  
These investigators ruled out the possibility that basal neuronal activity contributed to the 
generation of astrocyte Ca2+ events by recording astrocyte Ca2+ activity in the presence of 
tetrodotoxin (TTX) or Bafilomycin A1.  TTX blocks the generation of neuronal action 
potentials by inhibiting fast Na+ channels on neurons.  Bafilomycin prevents the filling of 
synaptic vesicles with neurotransmitter by inhibiting the vacuolar H+-ATPase pump 
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(Zhou et al., 2000).  In both cases, spontaneous astrocyte Ca2+ signals persisted in the 
absence of neurotransmitter release arguing against a role for neuronal input in the 
generation of astrocyte Ca2+ signals.  To examine the possibility that ambient levels of 
extracellular glutamate or ATP could trigger these apparently endogenous glial Ca2+ 
signals, Nett et al. (2002) recorded astrocyte Ca2+ activity before and after treatment with 
a cocktail of antagonists targeting metabotropic glutamatergic and purinergic receptors. 
As mentioned, both glutamate and ATP had been shown previously to trigger Ca2+ 
increases in astrocytes (Cornell-Bell et al., 1990; Kirischuk et al., 1995). Interestingly, 
bath application of these inhibitors had no effect on spontaneous astrocyte Ca2+ events.  
Based on these data, the authors concluded that the generation of spontaneous Ca2+ 
signals represents an intrinsic property of astrocytes that may function to modulate local 
neuronal activity.  It should be noted here that the authors focused primarily on events 
within astrocyte somata and perisynaptic processes.  There was no mention of 
spontaneous activity in perivascular endfeet.  
Astrocyte Ca2+ Signaling in Disease 
Given the role of spontaneous astrocyte Ca2+ signaling in modulating 
neurophysiology in the healthy brain, it stands to reason that aberrant astrocyte Ca2+ 
signals may be causally linked to brain dysfunction after injury or disease.  This concept 
is heavily supported by the literature.  Rodent models of epilepsy, Alzheimer’s disease 
and SAH have all reported changes in astrocyte Ca2+ signaling which are thought to 
contribute to the pathogenesis of their respective diseases.  For example, in a study 
measuring paroxysmal depolarization (PDS) of hippocampal neurons in situ, a 
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phenomenon involved in triggering epileptiform discharges, Tian et al. (2005) 
demonstrated strong evidence that aberrant astrocyte Ca2+ signaling preceded the 
generation of PDS in nearby clusters of neurons.  The authors subsequently confirmed 
this finding in vivo by simultaneously measuring astrocyte Ca2+ signals and extracellular 
field potentials in anesthetized animals.  Going one step further, the investigators then 
showed that pre-treatment of animals with antiepileptic drugs suppressed astrocyte Ca2+ 
oscillations and reduced seizure-like events.   
 The early stages of Alzheimer’s disease (AD) is accompanied by an impairment 
in neuronal activity-dependent vasodilation (i.e. neurovascular coupling) (Farkas and 
Luiten, 2001; Takano et al., 2007).   Consistent with a role for astrocyte endfoot Ca2+ 
signaling mediating local blood flow changes during neurovascular coupling, Takano et 
al. (2007) found that young (2-4 months old) AD model mice exhibiting such vascular 
instability also showed an increased frequency of spontaneous Ca2+ oscillations in 
cortical astrocytes.  Deposition of amyloid β along the walls of intra-cerebral micro-
vessels occurs early in AD model mice (Davis et al., 2004).  Takano et al. (2007) showed 
that treatment of mice with amyloid β caused a time-dependent increase in astrocyte Ca2+ 
signaling.  A more recent study expanded on these findings and demonstrated that the 
hyperactive Ca2+ signaling phenotype exhibited by astrocytes in AD could be normalized 
by inhibition of the Gq-coupled metabotropic purinergic receptor, P2Y1 (Delekate et al., 
2014).  Based on these data, it would appear that early deposition of amyloid β causes 
P2Y1-mediated enhancement of astrocyte Ca2+ signaling and disrupted neurovascular 
coupling.  It is likely that these deleterious changes subsequently lead to 
neurodegeneration and cognitive decline; the hallmarks of AD.   
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 In a rat model of aneurysmal SAH, Koide et al. (2012) found both an increase in 
the amplitude of spontaneous Ca2+ events in perivascular astrocyte endfeet and inversion 
of neurovascular coupling from vasodilation to vasoconstriction.  Although a causal link 
between these two phenomena has yet to be established, the functional consequences 
observed in the SAH model (increased amplitude of spontaneous Ca2+ events and 
inversion of neurovascular coupling) bear a striking resemblance to that which occurs 
early in AD.  Thus, it is possible that pathological changes in spontaneous astrocyte Ca2+ 
signaling precede the disruption of cerebral hemodynamics following SAH.     
 Astrocytes typically respond to CNS injury by undergoing a characteristic 
hypertrophy and hyperplasia, called reactive gliosis (Sofroniew, 2009; Burda and 
Sofroniew, 2014).  Reactive astrocytes can be observed in each of the disease models 
mentioned above (Wetherington et al., 2008; Heneka et al., 2005; Murakami et al., 2011; 
Delekate et al., 2014).  However, given the heterotypic responses of individual astrocytes 
to environmental signals following CNS perturbation, it would be difficult to determine 
whether reactive gliosis itself is accompanied by a predictable change in spontaneous 
astrocyte Ca2+ signaling.  Brain injury triggers a multi-cellular response and leads to the 
release of numerous factors, such as ATP, TNF-α and thrombin, that could conceivably 
impact astrocyte Ca2+ signaling (Shirawaka et al., 2010; Santello et al., 2011; Agulhon et 





Purine and Pyrimidine Nucleotides and their Receptors 
 Purine and pyrimidine nucleotides (e.g. ATP, ADP, adenosine, and UTP, UDP, 
respectively) contribute to a variety of cellular functions within the cytosol.  However, 
receptors for extracellular purine and pyrimidine nucleotides are found throughout the 
body and activation of these receptors leads to the transduction of a wide range of 
biological signals.  Drury and Szent-Gyorgin (1929) first proposed a role for extracellular 
signaling via purine nucleotides nearly a century ago when they discovered the 
cardiovascular effects of intravenous administration of adenosine.  Subsequent work by 
Gillespie (1934) demonstrated opposing actions of ATP and adenosine on intestinal 
smooth muscle contractility, indicating that these nucleotides may be signaling through 
different receptors.  Currently, we know there are two families of purine receptors: P1, 
which are activated by adenosine, and P2, which are activated by ATP, ADP, UTP, and 
UDP (Ralevic and Burnstock, 1998).  For the purposes of this dissertation, we will focus 
primarily on the P2 receptor family. 
 Purinergic P2 receptors can be subdivided into Ca2+-permeable (P2X) ion 
channels, or metabotropic G protein-coupled (P2Y) receptors.  There are seven P2X 
receptor subtypes (P2X1-P2X7) all of which are activated by extracellular ATP.  P2Y 
receptors, on the other hand, have eight different subtypes (P2Y1, P2Y2, P2Y4, P2Y6, 
P2Y11, P2Y12, P2Y13, and P2Y14) and are activated by a variety of extracellular ligands 
(ATP, ADP, UTP, and UDP) with varying degrees of affinity (Ralevic and Burnstock, 
1998).  Different P2Y receptors are coupled to different G proteins.  The receptors P2Y1-
6,11 are Gq-coupled and trigger an elevation of intracellular Ca2+ when activated, whereas 
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P2Y12-14 couple to Gi/o and reduce activity of adenylate cyclase.  The P2 family of 
receptors is broadly expressed throughout the brain and has been implicated in a variety 
of neuronal and glial functions in health and disease.   
Astrocyte Purinergic Signaling in Disease 
 Extracellular purine nucleotides are often elevated in the brain following a variety 
of CNS insults, including aneurysmal SAH (Kasseckert et al., 2013).  Damaged and/or 
dying cells represent one source of elevated ATP following brain injury.  However, 
astrocytes are generally considered to be the principal source of released ATP in the CNS 
(Franke et al., 2012).   Astrocytes can release ATP via Ca2+-dependent exocytosis (i.e. 
vesicular release) or through hemi-channels formed by connexins and pannexins 
(Montana et al., 2006; Bowser and Khakh, 2007; Kang et al., 2008).  Interestingly, 
astrocyte lysosomes have recently been identified as another potential source of released 
ATP in the brain, although this has only been observed in cultured cells (Zhang et al., 
2007).   
Astrocytes express many subtypes of P2X and P2Y receptors whose activation 
causes a rise in intra-cellular Ca2+ (for reviews see: Iles and Alexandre-Ribeiro, 2004, 
and Franke et al., 2012).  These P2 receptors regulate diverse functions such as 
proliferation/apoptosis (Neary et al., 1996), gliotransmission (Pannicke et al., 2000; Duan 
et al., 2003), and astrocyte reactivity (Brambilla et al., 1999; Abbracchio et al., 1999).  
Based largely on immuno-labeling studies, the Gq-coupled P2Y1, P2Y2, and P2Y4 
receptors have all been shown to be expressed on perivascular astrocyte endfeet (Simard 
et al., 2003; Franke et al., 2012).  Kasseckert et al. (2013) found that the ATP levels in 
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cerebrospinal fluid obtained from human SAH patients were roughly 400 times higher 
than that of non-SAH patients.  Under healthy conditions, cerebrospinal fluid is thought 
to flow into the brain parenchyma along a paravascular pathway between parenchymal 
arterioles and surrounding astrocyte endfeet (Iliff et al., 2012; Iliff et al., 2013).  Thus, it 
is conceivable that elevated levels of ATP and/or other purine nucleotides in the 
cerebrospinal fluid after SAH could trigger a pathological change in endfoot Ca2+ 
signaling (i.e. high-amplitude Ca2+ events).  The second specific aim of this dissertation is 
to determine whether purinergic signaling underlies the emergence of high-amplitude 





Figure 1-1.  Two potential pathways driving neurovascular coupling. 
Arachidonic acid (AA) could be released by phospholipase A2 (PLA2) following a 
neuronal activity-dependent elevation of endfoot Ca2+ (left of dotted line).  Enzymes 
within the endfoot may metabolize AA into prostaglandin E2 (PGE2) and/or 
epoxyeicosatrienoic acids (EETs) which could impact arteriolar diameter after diffusing 
across the perivascular space and entering the vascular smooth muscle.  However, AA 
itself may also diffuse across the perivascular space and impact arteriolar diameter after 
being converted to 20-hydroxyeicosatetraenoic acid (20-HETE) by smooth muscle 
enzymes.  Alternatively, the endfoot Ca2+ elevation could open large-conductance Ca2+-
activated K+ (BK) channels (right of dotted line).  Increased perivascular K+ would 
rapidly impact arteriolar diameter by directly influencing the smooth muscle membrane 








Figure 1-2.  Schematic depicting a mechanism whereby the increased amplitude of 
spontaneous endfoot Ca2+ events could lead to inversion of neurovascular coupling 
after SAH. 
In the absence of stimulation (left of dotted lines), perivascular astrocyte endfeet exhibit 
asynchronous spontaneous Ca2+ signaling events.  However, there is an increase in the 
amplitude of these events after SAH.  We hypothesize that the high-amplitude Ca2+ 
events in SAH animals cause excessive K+ efflux through endfoot BK channels leading 
to an abnormal elevation of perivascular K+.  Evoking a rise in endfoot Ca2+ either by 
electrical field stimulation (EFS) or Ca2+ uncaging (right of dotted lines) causes a modest 
BK channel-dependent elevation of extracellular K+.  In healthy control animals, this 
modest increase in perivascular K+ hyperpolarizes the vascular smooth muscle and causes 
arteriolar dilation.  In SAH animals, however, the stimulated K+ efflux could combine 
with abnormally elevated K+ levels to bring perivascular K+ beyond the 





Abbracchio MP, Brambilla R, Ceruti S, Cattabeni F (1999) Signalling mechanisms 
involved in P2Y receptor-mediated reactive astrogliosis. Prog Brain Res 120:333-
342. 
Agulhon C, Sun MY, Murphy T, Myers T, Lauderdale K, Fiacco TA (2012) Calcium 
Signaling and Gliotransmission in Normal vs. Reactive Astrocytes. Front 
Pharmacol 3:139. 
Ajiboye N, Chalouhi N, Starke RM, Zanaty M, Bell R (2015) Unruptured Cerebral 
Aneurysms: Evaluation and Management. Scientific World Journal 2015:954954. 
Al-Khindi T, Macdonald RL, Schweizer TA (2010) Cognitive and functional outcome 
after aneurysmal subarachnoid hemorrhage. Stroke 41:e519-e536. 
Alkayed NJ, Birks EK, Narayanan J, Petrie KA, Kohler-Cabot AE, Harder DR (1997) 
Role of P-450 arachidonic acid epoxygenase in the response of cerebral blood 
flow to glutamate in rats. Stroke 28:1066-1072. 
Alkayed NJ, Narayanan J, Gebremedhin D, Medhora M, Roman RJ, Harder DR (1996) 
Molecular characterization of an arachidonic acid epoxygenase in rat brain 
astrocytes. Stroke 27:971-979. 
Angulo MC, Kozlov AS, Charpak S, Audinat E (2004) Glutamate released from glial 
cells synchronizes neuronal activity in the hippocampus. J Neurosci 24:6920-
6927. 
Attwell D, Buchan AM, Charpak S, Lauritzen M, MacVicar BA, Newman EA (2010) 
Glial and neuronal control of brain blood flow. Nature 468:232-243. 
Baeres FM, Moller M (2004) Origin of PACAP-immunoreactive nerve fibers innervating 
the subarachnoidal blood vessels of the rat brain. J Cereb Blood Flow Metab 
24:628-635. 
Bai JP, Surguchev A, Navaratnam D (2011) β4-subunit increases Slo responsiveness to 
physiological Ca2+ concentrations and together with β1 reduces surface 
expression of Slo in hair cells. Am J Physiol Cell Physiol 300:C435-C446. 
Bayliss WM (1902) On the local reactions of the arterial wall to changes of internal 
pressure. J Physiol 28:220-231. 
Begley DJ, Brightman MW (2003) Structural and functional aspects of the blood-brain 
barrier. Prog Drug Res 61:39-78. 
32 
 
Benfenati V, Amiry-Moghaddam M, Caprini M, Mylonakou MN, Rapisarda C, Ottersen 
OP, Ferroni S (2007) Expression and functional characterization of transient 
receptor potential vanilloid-related channel 4 (TRPV4) in rat cortical astrocytes. 
Neuroscience 148:876-892. 
Bennett DA, Krishnamurthi RV, Barker-Collo S, Forouzanfar MH, Naghavi M, Connor 
M, Lawes CM, Moran AE, Anderson LM, Roth GA, Mensah GA, Ezzati M, 
Murray CJ, Feigin VL (2014) The global burden of ischemic stroke: findings of 
the GBD 2010 study. Glob Heart 9:107-112. 
Bonder DE, McCarthy KD (2014) Astrocytic Gq-GPCR-linked IP3R-dependent Ca2+ 
signaling does not mediate neurovascular coupling in mouse visual cortex in vivo. 
J Neurosci 34:13139-13150. 
Bowser DN, Khakh BS (2007) Vesicular ATP is the predominant cause of intercellular 
calcium waves in astrocytes. J Gen Physiol 129:485-491. 
Brambilla R, Burnstock G, Bonazzi A, Ceruti S, Cattabeni F, Abbracchio MP (1999) 
Cyclo-oxygenase-2 mediates P2Y receptor-induced reactive astrogliosis. Br J 
Pharmacol 126:563-567. 
Brayden JE, Li Y, Tavares MJ (2013) Purinergic receptors regulate myogenic tone in 
cerebral parenchymal arterioles. J Cereb Blood Flow Metab 33:293-299. 
Burda JE, Sofroniew MV (2014) Reactive gliosis and the multicellular response to CNS 
damage and disease. Neuron 81:229-248. 
Carmignoto G, Pasti L, Pozzan T (1998) On the role of voltage-dependent calcium 
channels in calcium signaling of astrocytes in situ. J Neurosci 18:4637-4645. 
Chen BR, Kozberg MG, Bouchard MB, Shaik MA, Hillman EM (2014) A critical role for 
the vascular endothelium in functional neurovascular coupling in the brain. J Am 
Heart Assoc 3:e000787. 
Chen J, Tan Z, Zeng L, Zhang X, He Y, Gao W, Wu X, Li Y, Bu B, Wang W, Duan S 
(2013) Heterosynaptic long-term depression mediated by ATP released from 
astrocytes. Glia 61:178-191. 
Cipolla MJ (2009) The Cerebral Circulation. 
Cipolla MJ, Li R, Vitullo L (2004) Perivascular innervation of penetrating brain 
parenchymal arterioles. J Cardiovasc Pharmacol 44:1-8. 
33 
 
Cornell-Bell AH, Finkbeiner SM, Cooper MS, Smith SJ (1990) Glutamate induces 
calcium waves in cultured astrocytes: long-range glial signaling. Science 247:470-
473. 
Dabertrand F, Hannah RM, Pearson JM, Hill-Eubanks DC, Brayden JE, Nelson MT 
(2013) Prostaglandin E2, a postulated astrocyte-derived neurovascular coupling 
agent, constricts rather than dilates parenchymal arterioles. J Cereb Blood Flow 
Metab 33:479-482. 
Davis J, Xu F, Deane R, Romanov G, Previti ML, Zeigler K, Zlokovic BV, Van Nostrand 
WE (2004) Early-onset and robust cerebral microvascular accumulation of 
amyloid β-protein in transgenic mice expressing low levels of a vasculotropic 
Dutch/Iowa mutant form of amyloid β-protein precursor. J Biol Chem 279:20296-
20306. 
Delekate A, Fuchtemeier M, Schumacher T, Ulbrich C, Foddis M, Petzold GC (2014) 
Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in vivo in 
an Alzheimer's disease mouse model. Nat Commun 5:5422. 
Dreier JP, Major S, Manning A, Woitzik J, Drenckhahn C, Steinbrink J, Tolias C, 
Oliveira-Ferreira AI, Fabricius M, Hartings JA, Vajkoczy P, Lauritzen M, Dirnagl 
U, Bohner G, Strong AJ (2009) Cortical spreading ischaemia is a novel process 
involved in ischaemic damage in patients with aneurysmal subarachnoid 
haemorrhage. Brain 132:1866-1881. 
Dreier JP, Sakowitz OW, Harder A, Zimmer C, Dirnagl U, Valdueza JM, Unterberg AW 
(2002) Focal laminar cortical MR signal abnormalities after subarachnoid 
hemorrhage. Ann Neurol 52:825-829. 
Drury AN, Szent-Gyorgyi A (1929) The physiological activity of adenine compounds 
with especial reference to their action upon the mammalian heart. J Physiol 
68:213-237. 
Duan S, Anderson CM, Keung EC, Chen Y, Chen Y, Swanson RA (2003) P2X7 receptor-
mediated release of excitatory amino acids from astrocytes. J Neurosci 23:1320-
1328. 
Dunn KM, Hill-Eubanks DC, Liedtke WB, Nelson MT (2013) TRPV4 channels stimulate 
Ca2+-induced Ca2+ release in astrocytic endfeet and amplify neurovascular 
coupling responses. Proc Natl Acad Sci U S A 110:6157-6162. 
Faraci FM, Heistad DD (1990) Regulation of large cerebral arteries and cerebral 
microvascular pressure. Circ Res 66:8-17. 
Farkas E, Luiten PG (2001) Cerebral microvascular pathology in aging and Alzheimer's 
disease. Prog Neurobiol 64:575-611. 
34 
 
Fatatis A, Russell JT (1992) Spontaneous changes in intracellular calcium concentration 
in type I astrocytes from rat cerebral cortex in primary culture. Glia 5:95-104. 
Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V (2009) Worldwide stroke 
incidence and early case fatality reported in 56 population-based studies: a 
systematic review. Lancet Neurol 8:355-369. 
Fiacco TA, McCarthy KD (2004) Intracellular astrocyte calcium waves in situ increase 
the frequency of spontaneous AMPA receptor currents in CA1 pyramidal 
neurons. J Neurosci 24:722-732. 
Filosa JA, Bonev AD, Straub SV, Meredith AL, Wilkerson MK, Aldrich RW, Nelson 
MT (2006) Local potassium signaling couples neuronal activity to vasodilation in 
the brain. Nat Neurosci 9:1397-1403. 
Filosa JA, Morrison HW, Iddings JA, Du W, Kim KJ (2015) Beyond neurovascular 
coupling, role of astrocytes in the regulation of vascular tone. Neuroscience. 
Franke H, Verkhratsky A, Burnstock G, Illes P (2012) Pathophysiology of astroglial 
purinergic signalling. Purinergic Signal 8:629-657. 
Gebremedhin D, Ma YH, Falck JR, Roman RJ, VanRollins M, Harder DR (1992) 
Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial 
smooth muscle. Am J Physiol 263:H519-H525. 
Gillespie JH (1934) The biological significance of the linkages in adenosine 
triphosphoric acid. J Physiol 80:345-359. 
Girouard H, Bonev AD, Hannah RM, Meredith A, Aldrich RW, Nelson MT (2010) 
Astrocytic endfoot Ca2+ and BK channels determine both arteriolar dilation and 
constriction. Proc Natl Acad Sci U S A 107:3811-3816. 
Hamel E (2006) Perivascular nerves and the regulation of cerebrovascular tone. J Appl 
Physiol (1985 ) 100:1059-1064. 
Harder DR, Gebremedhin D, Narayanan J, Jefcoat C, Falck JR, Campbell WB, Roman R 
(1994) Formation and action of a P-450 4A metabolite of arachidonic acid in cat 
cerebral microvessels. Am J Physiol 266:H2098-H2107. 
Haydon PG, Carmignoto G (2006) Astrocyte control of synaptic transmission and 
neurovascular coupling. Physiol Rev 86:1009-1031. 
Heilbrun MP, Olesen J, Lassen NA (1972) Regional cerebral blood flow studies in 
subarachnoid hemorrhage. J Neurosurg 37:36-44. 
35 
 
Heneka MT, Sastre M, Dumitrescu-Ozimek L, Dewachter I, Walter J, Klockgether T, 
Van LF (2005) Focal glial activation coincides with increased BACE1 activation 
and precedes amyloid plaque deposition in APP[V717I] transgenic mice. J 
Neuroinflammation 2:22. 
Henneberger C, Papouin T, Oliet SH, Rusakov DA (2010) Long-term potentiation 
depends on release of D-serine from astrocytes. Nature 463:232-236. 
Hirst WD, Young KA, Newton R, Allport VC, Marriott DR, Wilkin GP (1999) 
Expression of COX-2 by normal and reactive astrocytes in the adult rat central 
nervous system. Mol Cell Neurosci 13:57-68. 
Horrigan FT, Aldrich RW (2002) Coupling between voltage sensor activation, Ca2+ 
binding and channel opening in large conductance (BK) potassium channels. J 
Gen Physiol 120:267-305. 
Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, Benveniste H, Vates GE, 
Deane R, Goldman SA, Nagelhus EA, Nedergaard M (2012) A paravascular 
pathway facilitates CSF flow through the brain parenchyma and the clearance of 
interstitial solutes, including amyloid β. Sci Transl Med 4:147ra111. 
Iliff JJ, Wang M, Zeppenfeld DM, Venkataraman A, Plog BA, Liao Y, Deane R, 
Nedergaard M (2013) Cerebral arterial pulsation drives paravascular CSF-
interstitial fluid exchange in the murine brain. J Neurosci 33:18190-18199. 
Illes P, Alexandre RJ (2004) Molecular physiology of P2 receptors in the central nervous 
system. Eur J Pharmacol 483:5-17. 
Ishiguro M, Morielli AD, Zvarova K, Tranmer BI, Penar PL, Wellman GC (2006) 
Oxyhemoglobin-induced suppression of voltage-dependent K+ channels in 
cerebral arteries by enhanced tyrosine kinase activity. Circ Res 99:1252-1260. 
Jakubowski J, Kendall B (1978) Coincidental aneurysms with tumours of pituitary origin. 
J Neurol Neurosurg Psychiatry 41:972-979. 
Kang J, Kang N, Lovatt D, Torres A, Zhao Z, Lin J, Nedergaard M (2008) Connexin 43 
hemichannels are permeable to ATP. J Neurosci 28:4702-4711. 
Kasseckert SA, Shahzad T, Miqdad M, Stein M, Abdallah Y, Scharbrodt W, Oertel M 
(2013) The mechanisms of energy crisis in human astrocytes after subarachnoid 
hemorrhage. Neurosurgery 72:468-474. 
Kim KJ, Iddings JA, Stern JE, Blanco VM, Croom D, Kirov SA, Filosa JA (2015) 
Astrocyte contributions to flow/pressure-evoked parenchymal arteriole 
vasoconstriction. J Neurosci 35:8245-8257. 
36 
 
Kirischuk S, Moller T, Voitenko N, Kettenmann H, Verkhratsky A (1995) ATP-induced 
cytoplasmic calcium mobilization in Bergmann glial cells. J Neurosci 15:7861-
7871. 
Knot HJ, Zimmermann PA, Nelson MT (1996) Extracellular K+-induced 
hyperpolarizations and dilatations of rat coronary and cerebral arteries involve 
inward rectifier K+ channels. J Physiol 492 ( Pt 2):419-430. 
Koehler RC, Roman RJ, Harder DR (2009) Astrocytes and the regulation of cerebral 
blood flow. Trends Neurosci 32:160-169. 
Koide M, Bonev AD, Nelson MT, Wellman GC (2012) Inversion of neurovascular 
coupling by subarachnoid blood depends on large-conductance Ca2+-activated K+ 
(BK) channels. Proc Natl Acad Sci U S A 109:E1387-E1395. 
Koide M, Penar PL, Tranmer BI, Wellman GC (2007) Heparin-binding EGF-like growth 
factor mediates oxyhemoglobin-induced suppression of voltage-dependent 
potassium channels in rabbit cerebral artery myocytes. Am J Physiol Heart Circ 
Physiol 293:H1750-H1759. 
Koide M, Wellman GC (2013) SAH-induced suppression of voltage-gated K+ (KV) 
channel currents in parenchymal arteriolar myocytes involves activation of the 
HB-EGF/EGFR pathway. Acta Neurochir Suppl 115:179-184. 
Koide M, Wellman GC (2015) Activation of TRPV4 channels does not mediate inversion 
of neurovascular coupling after SAH. Acta Neurochir Suppl 120:111-116. 
Krimer LS, Muly EC, III, Williams GV, Goldman-Rakic PS (1998) Dopaminergic 
regulation of cerebral cortical microcirculation. Nat Neurosci 1:286-289. 
Krishnamurthi RV, Moran AE, Forouzanfar MH, Bennett DA, Mensah GA, Lawes CM, 
Barker-Collo S, Connor M, Roth GA, Sacco R, Ezzati M, Naghavi M, Murray CJ, 
Feigin VL (2014) The global burden of hemorrhagic stroke: a summary of 
findings from the GBD 2010 study. Glob Heart 9:101-106. 
Latour I, Hamid J, Beedle AM, Zamponi GW, MacVicar BA (2003) Expression of 
voltage-gated Ca2+ channel subtypes in cultured astrocytes. Glia 41:347-353. 
Li Y, Baylie RL, Tavares MJ, Brayden JE (2014) TRPM4 channels couple purinergic 
receptor mechanoactivation and myogenic tone development in cerebral 
parenchymal arterioles. J Cereb Blood Flow Metab 34:1706-1714. 
Link TE, Murakami K, Beem-Miller M, Tranmer BI, Wellman GC (2008) 




Longden TA, Nelson MT (2015) Vascular inward rectifier K+ channels as external K+ 
sensors in the control of cerebral blood flow. Microcirculation 22:183-196. 
Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, 
Wanke I, Bach D, Frey A, Marr A, Roux S, Kassell N (2011) Clazosentan, an 
endothelin receptor antagonist, in patients with aneurysmal subarachnoid 
haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-
controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 10:618-625. 
Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, 
Wanke I, Bach D, Frey A, Nowbakht P, Roux S, Kassell N (2012) Randomized 
trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage 
undergoing endovascular coiling. Stroke 43:1463-1469. 
MacVicar BA (1984) Voltage-dependent calcium channels in glial cells. Science 
226:1345-1347. 
MacVicar BA, Hochman D, Delay MJ, Weiss S (1991) Modulation of intracellular Ca2+ 
in cultured astrocytes by influx through voltage-activated Ca2+ channels. Glia 
4:448-455. 
Mathiisen TM, Lehre KP, Danbolt NC, Ottersen OP (2010) The perivascular astroglial 
sheath provides a complete covering of the brain microvessels: an electron 
microscopic 3D reconstruction. Glia 58:1094-1103. 
McCaslin AF, Chen BR, Radosevich AJ, Cauli B, Hillman EM (2011) In vivo 3D 
morphology of astrocyte-vasculature interactions in the somatosensory cortex: 
implications for neurovascular coupling. J Cereb Blood Flow Metab 31:795-806. 
Mocco J, Komotar RJ, Lavine SD, Meyers PM, Connolly ES, Solomon RA (2004) The 
natural history of unruptured intracranial aneurysms. Neurosurg Focus 17:E3. 
Montana V, Malarkey EB, Verderio C, Matteoli M, Parpura V (2006) Vesicular 
transmitter release from astrocytes. Glia 54:700-715. 
Mulligan SJ, MacVicar BA (2004) Calcium transients in astrocyte endfeet cause 
cerebrovascular constrictions. Nature 431:195-199. 
Murakami K, Koide M, Dumont TM, Russell SR, Tranmer BI, Wellman GC (2011) 
Subarachnoid Hemorrhage Induces Gliosis and Increased Expression of the Pro-
inflammatory Cytokine High Mobility Group Box 1 Protein. Transl Stroke Res 
2:72-79. 
Navarrete M, Araque A (2014) The Cajal school and the physiological role of astrocytes: 
a way of thinking. Front Neuroanat 8:33. 
38 
 
Navarrete M, Perea G, Fernandez de SD, Gomez-Gonzalo M, Nunez A, Martin ED, 
Araque A (2012) Astrocytes mediate in vivo cholinergic-induced synaptic 
plasticity. PLoS Biol 10:e1001259. 
Navarrete M, Perea G, Maglio L, Pastor J, Garcia de SR, Araque A (2013) Astrocyte 
calcium signal and gliotransmission in human brain tissue. Cereb Cortex 23:1240-
1246. 
Neary JT, Rathbone MP, Cattabeni F, Abbracchio MP, Burnstock G (1996) Trophic 
actions of extracellular nucleotides and nucleosides on glial and neuronal cells. 
Trends Neurosci 19:13-18. 
Nedergaard M (1994) Direct signaling from astrocytes to neurons in cultures of 
mammalian brain cells. Science 263:1768-1771. 
Nett WJ, Oloff SH, McCarthy KD (2002) Hippocampal astrocytes in situ exhibit calcium 
oscillations that occur independent of neuronal activity. J Neurophysiol 87:528-
537. 
Newman EA (1984) Regional specialization of retinal glial cell membrane. Nature 
309:155-157. 
Newman EA (1986) High potassium conductance in astrocyte endfeet. Science 233:453-
454. 
Newman EA, Zahs KR (1997) Calcium waves in retinal glial cells. Science 275:844-847. 
Nishimura N, Rosidi NL, Iadecola C, Schaffer CB (2010) Limitations of collateral flow 
after occlusion of a single cortical penetrating arteriole. J Cereb Blood Flow 
Metab 30:1914-1927. 
Nizar K, et al. (2013) In vivo stimulus-induced vasodilation occurs without IP3 receptor 
activation and may precede astrocytic calcium increase. J Neurosci 33:8411-8422. 
Nystoriak MA, O'Connor KP, Sonkusare SK, Brayden JE, Nelson MT, Wellman GC 
(2011) Fundamental increase in pressure-dependent constriction of brain 
parenchymal arterioles from subarachnoid hemorrhage model rats due to 
membrane depolarization. Am J Physiol Heart Circ Physiol 300:H803-H812. 
Ostergaard L, Aamand R, Karabegovic S, Tietze A, Blicher JU, Mikkelsen IK, Iversen 
NK, Secher N, Engedal TS, Anzabi M, Jimenez EG, Cai C, Koch KU, Naess-
Schmidt ET, Obel A, Juul N, Rasmussen M, Sorensen JC (2013) The role of the 
microcirculation in delayed cerebral ischemia and chronic degenerative changes 
after subarachnoid hemorrhage. J Cereb Blood Flow Metab 33:1825-1837. 
39 
 
Pannicke T, Fischer W, Biedermann B, Schadlich H, Grosche J, Faude F, Wiedemann P, 
Allgaier C, Illes P, Burnstock G, Reichenbach A (2000) P2X7 receptors in Muller 
glial cells from the human retina. J Neurosci 20:5965-5972. 
Park IS, Meno JR, Witt CE, Chowdhary A, Nguyen TS, Winn HR, Ngai AC, Britz GW 
(2009) Impairment of intracerebral arteriole dilation responses after subarachnoid 
hemorrhage. Laboratory investigation. J Neurosurg 111:1008-1013. 
Parri HR, Crunelli V (2003) The role of Ca2+ in the generation of spontaneous astrocytic 
Ca2+ oscillations. Neuroscience 120:979-992. 
Parri HR, Gould TM, Crunelli V (2001) Spontaneous astrocytic Ca2+ oscillations in situ 
drive NMDAR-mediated neuronal excitation. Nat Neurosci 4:803-812. 
Pascual O, Ben AS, Rostaing P, Triller A, Bessis A (2012) Microglia activation triggers 
astrocyte-mediated modulation of excitatory neurotransmission. Proc Natl Acad 
Sci U S A 109:E197-E205. 
Passier PE, Visser-Meily JM, Rinkel GJ, Lindeman E, Post MW (2013) Determinants of 
health-related quality of life after aneurysmal subarachnoid hemorrhage: a 
systematic review. Qual Life Res 22:1027-1043. 
Paulson OB, Newman EA (1987) Does the release of potassium from astrocyte endfeet 
regulate cerebral blood flow? Science 237:896-898. 
Perea G, Araque A (2007) Astrocytes potentiate transmitter release at single hippocampal 
synapses. Science 317:1083-1086. 
Peters DG, Kassam AB, Feingold E, Heidrich-O'Hare E, Yonas H, Ferrell RE, Brufsky A 
(2001) Molecular anatomy of an intracranial aneurysm: coordinated expression of 
genes involved in wound healing and tissue remodeling. Stroke 32:1036-1042. 
Pluta RM, Hansen-Schwartz J, Dreier J, Vajkoczy P, Macdonald RL, Nishizawa S, 
Kasuya H, Wellman G, Keller E, Zauner A, Dorsch N, Clark J, Ono S, Kiris T, 
Leroux P, Zhang JH (2009) Cerebral vasospasm following subarachnoid 
hemorrhage: time for a new world of thought. Neurol Res 31:151-158. 
Porter JT, McCarthy KD (1996) Hippocampal astrocytes in situ respond to glutamate 
released from synaptic terminals. J Neurosci 16:5073-5081. 
Price DL, Ludwig JW, Mi H, Schwarz TL, Ellisman MH (2002) Distribution of rSlo 
Ca2+-activated K+ channels in rat astrocyte perivascular endfeet. Brain Res 
956:183-193. 
Rabinstein AA, Weigand S, Atkinson JL, Wijdicks EF (2005) Patterns of cerebral 
infarction in aneurysmal subarachnoid hemorrhage. Stroke 36:992-997. 
40 
 
Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 
50:413-492. 
Reinhard JF, Jr., Liebmann JE, Schlosberg AJ, Moskowitz MA (1979) Serotonin neurons 
project to small blood vessels in the brain. Science 206:85-87. 
Roy CS, Sherrington CS (1890) On the regulation of the blood-supply of the brain. J 
Physiol 11:85-158. 
Santello M, Bezzi P, Volterra A (2011) TNFα controls glutamatergic gliotransmission in 
the hippocampal dentate gyrus. Neuron 69:988-1001. 
Seidel KN, Derst C, Salzmann M, Holtje M, Priller J, Markgraf R, Heinemann SH, 
Heilmann H, Skatchkov SN, Eaton MJ, Veh RW, Pruss H (2011) Expression of 
the voltage- and Ca2+-dependent BK potassium channel subunits BKβ1 and BKβ4 
in rodent astrocytes. Glia 59:893-902. 
Shao Y, McCarthy KD (1995) Receptor-mediated calcium signals in astroglia: multiple 
receptors, common stores and all-or-nothing responses. Cell Calcium 17:187-196. 
Shelton MK, McCarthy KD (1999) Mature hippocampal astrocytes exhibit functional 
metabotropic and ionotropic glutamate receptors in situ. Glia 26:1-11. 
Shelton MK, McCarthy KD (2000) Hippocampal astrocytes exhibit Ca2+-elevating 
muscarinic cholinergic and histaminergic receptors in situ. J Neurochem 74:555-
563. 
Shigetomi E, Bushong EA, Haustein MD, Tong X, Jackson-Weaver O, Kracun S, Xu J, 
Sofroniew MV, Ellisman MH, Khakh BS (2013) Imaging calcium microdomains 
within entire astrocyte territories and endfeet with GCaMPs expressed using 
adeno-associated viruses. J Gen Physiol 141:633-647. 
Shirakawa H, Sakimoto S, Nakao K, Sugishita A, Konno M, Iida S, Kusano A, 
Hashimoto E, Nakagawa T, Kaneko S (2010) Transient receptor potential 
canonical 3 (TRPC3) mediates thrombin-induced astrocyte activation and 
upregulates its own expression in cortical astrocytes. J Neurosci 30:13116-13129. 
Simard M, Arcuino G, Takano T, Liu QS, Nedergaard M (2003) Signaling at the 
gliovascular interface. J Neurosci 23:9254-9262. 
Sofroniew MV (2009) Molecular dissection of reactive astrogliosis and glial scar 
formation. Trends Neurosci 32:638-647. 
Solomon RA, Antunes JL, Chen RY, Bland L, Chien S (1985) Decrease in cerebral blood 




Srinivasan R, Huang BS, Venugopal S, Johnston AD, Chai H, Zeng H, Golshani P, 
Khakh BS (2015) Ca2+ signaling in astrocytes from IP3R2-/- mice in brain slices 
and during startle responses in vivo. Nat Neurosci 18:708-717. 
Straub SV, Bonev AD, Wilkerson MK, Nelson MT (2006) Dynamic inositol 
trisphosphate-mediated calcium signals within astrocytic endfeet underlie 
vasodilation of cerebral arterioles. J Gen Physiol 128:659-669. 
Takano T, Han X, Deane R, Zlokovic B, Nedergaard M (2007) Two-photon imaging of 
astrocytic Ca2+ signaling and the microvasculature in experimental mice models 
of Alzheimer's disease. Ann N Y Acad Sci 1097:40-50. 
Takano T, Tian GF, Peng W, Lou N, Libionka W, Han X, Nedergaard M (2006) 
Astrocyte-mediated control of cerebral blood flow. Nat Neurosci 9:260-267. 
Tian GF, Azmi H, Takano T, Xu Q, Peng W, Lin J, Oberheim N, Lou N, Wang X, Zielke 
HR, Kang J, Nedergaard M (2005) An astrocytic basis of epilepsy. Nat Med 
11:973-981. 
Trachtenberg MC, Pollen DA (1970) Neuroglia: biophysical properties and physiologic 
function. Science 167:1248-1252. 
Vander Eecken HM, Adams RD (1953) The anatomy and functional significance of the 
meningeal arterial anastomoses of the human brain. J Neuropathol Exp Neurol 
12:132-157. 
Vatter H, Weidauer S, Konczalla J, Dettmann E, Zimmermann M, Raabe A, Preibisch C, 
Zanella FE, Seifert V (2006) Time course in the development of cerebral 
vasospasm after experimental subarachnoid hemorrhage: clinical and 
neuroradiological assessment of the rat double hemorrhage model. Neurosurgery 
58:1190-1197. 
Vaucher E, Hamel E (1995) Cholinergic basal forebrain neurons project to cortical 
microvessels in the rat: electron microscopic study with anterogradely transported 
Phaseolus vulgaris leucoagglutinin and choline acetyltransferase 
immunocytochemistry. J Neurosci 15:7427-7441. 
Verkhratsky A, Orkand RK, Kettenmann H (1998) Glial calcium: homeostasis and 
signaling function. Physiol Rev 78:99-141. 
Weidauer S, Vatter H, Beck J, Raabe A, Lanfermann H, Seifert V, Zanella F (2008) 
Focal laminar cortical infarcts following aneurysmal subarachnoid haemorrhage. 
Neuroradiology 50:1-8. 




Wetherington J, Serrano G, Dingledine R (2008) Astrocytes in the epileptic brain. 
Neuron 58:168-178. 
Winship IR, Plaa N, Murphy TH (2007) Rapid astrocyte calcium signals correlate with 
neuronal activity and onset of the hemodynamic response in vivo. J Neurosci 
27:6268-6272. 
Zaritsky JJ, Eckman DM, Wellman GC, Nelson MT, Schwarz TL (2000) Targeted 
disruption of Kir2.1 and Kir2.2 genes reveals the essential role of the inwardly 
rectifying K+ current in K+-mediated vasodilation. Circ Res 87:160-166. 
Zhang Z, Chen G, Zhou W, Song A, Xu T, Luo Q, Wang W, Gu XS, Duan S (2007) 
Regulated ATP release from astrocytes through lysosome exocytosis. Nat Cell 
Biol 9:945-953. 
Zhou Q, Petersen CC, Nicoll RA (2000) Effects of reduced vesicular filling on synaptic 
transmission in rat hippocampal neurones. J Physiol 525 Pt 1:195-206. 
Zingesser LH, Schechter MM, Dexter J, Katzman R, Scheinberg LC (1968) On the 
significance of spasm associated with rupture of a cerebral aneurysm. The 
relationship between spasm as noted angiographically and regional blood flow 
determinations. Arch Neurol 18:520-528. 
Zonta M, Angulo MC, Gobbo S, Rosengarten B, Hossmann KA, Pozzan T, Carmignoto 
G (2003a) Neuron-to-astrocyte signaling is central to the dynamic control of brain 
microcirculation. Nat Neurosci 6:43-50. 
Zonta M, Sebelin A, Gobbo S, Fellin T, Pozzan T, Carmignoto G (2003b) Glutamate-
mediated cytosolic calcium oscillations regulate a pulsatile prostaglandin release 
from cultured rat astrocytes. J Physiol 553:407-414. 
43 
 
Chapter 2: Astrocyte Ca2+ signaling drives inversion of neurovascular 
coupling after subarachnoid hemorrhage 
 
Anthony C. Pappas1, Masayo Koide1, George C. Wellman1,2 
 
 
Departments of Pharmacology1 and Surgery2, Division of Neurosurgery, University of 







Physiologically, neurovascular coupling (NVC) matches focal increases in neuronal 
activity with local arteriolar dilation.  Astrocytes participate in NVC by sensing increased 
neurotransmission and releasing vasoactive agents (e.g. K+) from perivascular endfeet 
surrounding parenchymal arterioles.  Recently, we demonstrated an increase in the 
amplitude of spontaneous Ca2+ events in astrocyte endfeet and inversion of NVC from 
vasodilation to vasoconstriction in brain slices obtained from subarachnoid hemorrhage 
(SAH) model rats.  However, the role of spontaneous astrocyte Ca2+ signaling in 
determining the polarity of the NVC response remains unclear.   Here, we used two-
photon imaging of Fluo-4-loaded rat brain slices to determine whether altered endfoot 
Ca2+ signaling underlies SAH-induced inversion of NVC.  We report a time-dependent 
emergence of endfoot high-amplitude Ca2+ signals (eHACSs) after SAH that were not 
observed in endfeet from un-operated animals.  Further, the percentage of endfeet with 
eHACS varied with time and paralleled the development of inversion of NVC.  Endfeet 
with eHACS were present only around arterioles exhibiting inversion of NVC.  
Importantly, depletion of intracellular Ca2+ stores using cyclopiazonic acid abolished 
SAH-induced eHACS and restored arteriolar dilation in SAH brain slices to two 
mediators of NVC (a rise in endfoot Ca2+ and elevation of extracellular K+).  These data 
indicate a causal link between SAH-induced eHACS and inversion of NVC.  
Ultrastructural examination using transmission electron microscopy indicated that a 
similar proportion of endfeet exhibiting eHACS also exhibited asymmetrical 
enlargement.  Our results demonstrate that subarachnoid blood causes a delayed increase 
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Blood flow within the brain parenchyma is dynamically coupled to the ongoing 
pattern of neuronal activity.  Under physiological conditions, stimulus-evoked increases 
in the frequency of neuronal action potentials elicit vasodilation of nearby parenchymal 
arterioles. This phenomenon, called functional hyperemia, or neurovascular coupling 
(NVC), supports brain health by spatially and temporally matching cerebral blood flow to 
local tissue metabolic demand (Iadecola, 1993; Anderson and Nedergaard, 2003).  
Astrocytes are key intermediaries in NVC—having projections to neuronal synapses as 
well as processes (endfeet) that encase parenchymal arterioles (Araque et al., 1999). In 
response to enhanced neurotransmission, astrocytes release vasoactive substances, 
including potassium ions (K+), from their endfeet onto adjacent parenchymal arterioles 
(Zonta et al., 2003; Filosa et al., 2006).  The majority of evidence supports a role for 
increased astrocyte endfoot Ca2+ in mediating neurally-evoked vasodilator release (Straub 
et al., 2006; Attwell et al., 2010; Srinivasan et al., 2015;).   
 In addition to nerve-stimulated increases in Ca2+, spontaneous Ca2+ elevations 
(200-300 nM in amplitude) lasting several seconds occur in astrocyte endfeet (Koide et 
al., 2012; Shigetomi et al., 2013).  In brain slices from healthy animals, these spontaneous 
events resulted from IP3-dependent endoplasmic reticulum (ER) Ca2+ release (Dunn et 
al., 2013).  Presently, the ability of spontaneous Ca2+ signaling to influence NVC and/or 
the release of vasoactive substances into the restricted perivascular space between endfeet 
and parenchymal arterioles is unclear. However, we have recently demonstrated both an 
increase in the amplitude of spontaneous Ca2+ events in astrocyte endfeet and inversion 
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of the NVC response from vasodilation to vasoconstriction in brain slices obtained from 
subarachnoid hemorrhage (SAH) model rats (Koide et al., 2012; Koide and Wellman, 
2015).  Interestingly, although the NVC response switched from vasodilation to 
vasoconstriction, neurally-evoked changes in endfoot Ca2+ were not altered by SAH.  
Strokes caused by cerebral aneurysm rupture and SAH are associated with a high 
incidence of morbidity and mortality that often manifest several days after the initial 
bleed (Al-Khindi et al., 2010; Ostergaard et al., 2013).  The inversion of NVC may be an 
important contributor to delayed cerebral ischemia, development of neurological deficits 
and poor outcome frequently observed in SAH patients (Koide et al., 2013).  The goal of 
the present study was to determine if altered spontaneous Ca2+ signaling in astrocyte 
endfeet plays a causal role in the inversion of NVC after SAH.  Here, we report that the 
time-dependent emergence of high-amplitude spontaneous Ca2+ signals in astrocyte 
endfeet paralleled the occurrence of inversion of NVC in brain slices from SAH model 
rats.  These endfoot high-amplitude Ca2+ signals (eHACSs) were only observed adjacent 
to arterioles exhibiting inversion of NVC.  Importantly, normal arteriolar dilation was 
restored in brain slices from SAH animals when eHACSs were abolished by depletion of 
ER Ca2+ stores.  These results indicate that subarachnoid blood causes an increase in the 
amplitude of spontaneous Ca2+ signaling events in astrocyte endfeet that leads to 
inversion of NVC.  Further, this work signifies that pathological changes in astrocyte 




Materials and Methods 
Rat SAH model.  To mimic aneurysmal SAH, isoflurane-anesthetized Sprague-Dawley 
rats (male, 10-12 week old, Charles River Laboratories) received two injections of 
autologous, unheparanized arterial blood (500 µL drawn from tail artery) into the cisterna 
magna as previously described (Nystoriak et al., 2011; Koide et al., 2012).  Blood 
injections were given 24 h apart with the exception of animals studied at the 4 h and 24 h 
time-points that received only one intracisternal injection.  Sham-operated animals 
underwent identical procedures except that saline, rather than blood, was injected into the 
cisterna magna.  All procedures were conducted in accordance with the Guide for the 
Care and Use of Laboratory Animals (eighth edition, 2011) and followed protocols 
approved by the Institutional Animal Care and Use Committee at the University of 
Vermont.   
Simultaneous measurements of parenchymal arteriolar diameter and astrocyte endfoot 
Ca2+ in freshly prepared cortical brain slices.   
Brain slice preparation:  Animals were euthanized by decapitation while under deep 
anesthesia with pentobarbital (60 mg/kg) at the following time-points:  4 h, 24 h, and 2, 4, 
7, and 14 d after SAH.    Brains were removed from animals and placed in ice-cold, 
aerated (5% CO2/95% O2) artificial cerebrospinal fluid (ACSF) and coronal brain slices, 
160 µm in thickness, were cut from the middle cerebral artery (MCA) territory using a 
Leica VT1000S vibratome.  Brain slices were then incubated with the fluorescent Ca2+ 
indicator dye, Fluo-4 AM (10 µM) for 1.5 hr at 29°C in ACSF containing 0.04% pluronic 
acid.  Using these parameters, Fluo-4 is preferentially loaded into astrocytes (Parri et al., 
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2001; Kawamura and Kawamura, 2011).  In a subset of brain slices, the caged-Ca2+ 
compound, 1-(4,5-dimethoxy-2-nitrophenyl)-1,2-diaminoethane-N,N,N’,N’-tetraacetic 
acid, tetra(acetoxymethyl ester) (DMNP-EDTA AM, 10 µM) was included with the Fluo-
4.  Brain slices were then rinsed and maintained in aerated ACSF at room temperature 
until imaged.   
Simultaneous measurements of arteriolar diameter and astrocyte endfoot Ca2+:  Infrared-
differential interference contrast (IR-DIC) and fluorescent images were simultaneously 
recorded from brain slices using multiphoton imaging systems coupled to a Coherent 
Chameleon Ti-Sapphire laser.  A BioRad Radiance multi-photon imaging system 
(excitation wavelength: 820 nm, fluorescent bandpass filter: 575/150 nm, sampling 
frequency ~1 Hz) with an Olympus XLUM PlanF1 20x objective (0.95 NA) was used for 
the majority of studies.  For these experiments, image size was 512 x 512 pixels and pixel 
resolution was 0.12 µm/pixel.  For studies requiring the photolysis of caged Ca2+, a Zeiss 
LSM-7 multi-photon imaging system (excitation: 730 nm, fluorescent bandpass filter: 
525/50 nm, sampling frequency ~2 Hz) was used with a Zeiss W Plan-APOCHROMAT 
20x objective (1.0 NA).  The image size for these experiments was 512 x 300 pixels, and 
pixel resolution was 0.17 µm/pixel.  To study NVC, electrical field stimulation (EFS; 50 
Hz, 0.3 ms alternating square pulse, 3 s duration) was applied using a pair of platinum 
wire electrodes (2 mm apart) to trigger neuronal action potentials (Koide et. al., 2012).  
To elevate astrocyte endfoot Ca2+ independent of neuronal activation, we used photolysis 
of caged-Ca2+ or “Ca2+ uncaging” in DMNP-EDTA-loaded slices.  Photolysis was 
achieved using a ~0.5 s laser pulse of approximately three times the average imaging 
power to uncage Ca2+ within a selected endfoot (excitation volume of ~1 µm3).  
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Throughout all recordings, brain slices were continually superfused (≈ 2 mL/min) with 
ACSF (aerated with 5% CO2/95% O2, pH ~7.35, 35-37°C) containing the thromboxane 
A2 analog, 9,11 di-dideoxy-11α,9α-epoxymethanoprostaglandin F2α (U46619, 100 nM) 
to induce a physiological level of arteriolar tone (Koide et al., 2012).  Parenchymal 
arteriolar segments (diameter: 3-14 µm before EFS) within the MCA territory, located at 
a depth of 50-250 µm from the pial surface and surrounded by Fluo-4-loaded endfeet 
were chosen for this study.  Intraluminal red blood cells were observed in the majority of 
recordings (89%) and their presence or absence did not correlate with a particular 
vascular response to EFS or uncaging.  At the end of each experiment, brain slices were 
treated with ionomycin (10 µM) and 20 mM CaCl2 to obtain maximum fluorescence 
intensity. 
Analysis of parenchymal arteriolar diameter:  Using IR-DIC images, intraluminal 
parenchymal arteriolar diameter was measured at 3 evenly spaced points along a 10 µm 
segment showing the greatest response to stimulation (EFS, Ca2+ uncaging or 10 mM K+ 
superfusion).  Diameter change, expressed as percent increase or decrease from baseline 
diameter was determined from 10 s of recording prior to stimulation and then averaged 
for the three points of measurement.  Diameter measurements were made manually using 
custom software, SparkAn, written by Dr. Adrian D. Bonev, at the University of Vermont 
(Burlington, VT).  
Analysis of astrocyte endfoot Ca2+:  A region of interest (ROI; 1.2 x 1.2 µm) was placed 
within an astrocyte endfoot that was either (1) adjacent to an arteriolar segment used to 
measure diameter change after EFS or Ca2+ uncaging or (2) exhibiting spontaneous Ca2+ 
events in unstimulated brain slices.  Baseline Ca2+ within a ROI was determined by 
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averaging 10 consecutive images prior to stimulation and/or exhibiting no spontaneous 
activity.  The following criteria were used to define spontaneous Ca2+ events: (1) ≥30% 
increase in fluorescence intensity for at least 2 consecutive images (~2 s) and (2) multiple 
events observed within a ROI during a 4 min recording.  The maximal fluorescence 
method was used to estimate Ca2+ concentrations within a ROI (Maravall et al., 2000; 
Koide et al., 2012). 
Ultrastructural analysis using electron microscopy.   
Transmission electron microscopy (TEM) was used to examine brain parenchymal 
arterioles and surrounding astrocyte endfeet in cortical layer 2/3 of the MCA territory 
(i.e. the same region examined in brain slice studies).  Specimens were prepared for TEM 
using standard procedures (Hayat, 1981).  Briefly, un-operated control, 2 d sham-
operated and 2 d SAH model rats were anesthetized with pentobarbital (60 mg/kg) and 
fixed by transcardial perfusion at an intravascular pressure of 75 mmHg using a solution 
containing 135 mM Sucrose, 0.085 mM NaH2PO4, 0.5 mM CaCl2 and 1% glutaraldehyde 
(pH 7.3).  Brains were then dissected from animals and fixed in 1% glutaraldehyde for an 
additional 24 h.  Cortical blocks were cut, rinsed in 0.1 M cacodylate buffer and 
immersed in 1% OsO4 for 4 h at 4°C and then dehydrated using a series of graded ethanol 
and propylene oxide solutions, and embedded in Spurr’s resin overnight at 60° C.  
Ultrathin (90 nm) sections obtained using an Ultracut microtome were contrasted with 
uranyl acetate and lead citrate.  A Jeol 1400 Transmission Electron Microscope was used 
to obtain a series of non-overlapping images (magnification: 5000X) capturing the entire 
arteriolar circumference.  Consistent with previous reports (Mathiisen et al., 2010; 
McCaslin et al., 2011) the cellular structures providing sheath-like coverage of the 
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abluminal surface of the arteriolar wall were identified as astrocyte endfeet.  The distance 
between endfeet and arteriolar smooth muscle was considered as the perivascular space.  
Endfoot thickness and the perivascular space were measured at 10 random, equally-
spaced points along the arteriolar circumference using ImageJ (NIH).    
Statistical analysis.   
Data are expressed as mean ± SEM (n: the number of observations, N: the number of 
animals).  Unpaired Student’s two-tailed t test was used for comparisons between two 
groups.  One-way analysis of variance (ANOVA) followed by either the Tukey or 
Bonferroni test were used for the post hoc comparison of multiple groups.  Chi-squared 
analysis was used to determine dependence between variables. 
Reagents.   
U46619, cyclopiazonic acid (CPA), and ionomycin were obtained from Calbiochem 
(EMD Millipore, Chicago, IL).  DMNP-EDTA AM was purchased from Interchim 
(Montluçon, France).  Fluo-4 AM and pluronic acid were obtained from Invitrogen (Life 
Technologies, Eugene, OR).  All other reagents were purchased from Sigma-Aldrich (St. 
Louis, MO). The composition of aCSF (in mM) was: 125 NaCl, 3 KCl, 18 NaHCO3, 1.25 
NaH2PO4, 1 MgCl2, 2 CaCl2, 5 glucose and 0.4 ascorbic acid.  ACSF containing 10 mM 





The emergence of high-amplitude spontaneous Ca2+ events in astrocyte endfeet 
(eHACSs) after SAH 
 To explore the relationship between the inversion of NVC and the occurrence of 
high-amplitude spontaneous Ca2+ signals in astrocyte endfeet, cortical brain slices from 
the MCA territory were studied from SAH model rats at six time-points following 
injection of blood into the subarachnoid space (4 h, 24 h, and 2, 4, 7, and 14 d).  A 
subarachnoid blood clot was observed adjacent to the circle of Willis on the ventral 
surface of the brain between the 4 h and 4 d SAH time-points.  However, at days 7 and 14 
d post-SAH the clot was no longer visible.  Although remote from the site of blood 
injection (i.e. cisterna magna), extravascular red blood cells have been observed around 
parenchymal arterioles from the MCA territory using this model of SAH (Koide et al., 
2012).  Spontaneous Ca2+ events were imaged using two-photon excitation microscopy 
and the fluorescent Ca2+ indicator, Fluo-4, in astrocyte endfeet surrounding parenchymal 
arterioles (Fig. 1A,B).  Consistent with our previous observation (Koide et al., 2012), 
SAH led to a significant increase in the overall mean amplitude of spontaneous Ca2+ 
events following SAH (F[6,523] = 5.75; ANOVA, p < 0.0001).  Post hoc comparison of the 
means (Bonferroni) revealed significance at the 24 h, 2, 4, and 7 d SAH time-points (p = 
0.01, p = 0.0002, p = 0.004, p = 0.03, respectively).  With further analysis, we determined 
that the increased mean amplitudes were due to the emergence of a sub-population of 
high-amplitude Ca2+ events not observed in control animals.  In brain slices from un-
operated control animals, basal endfoot Ca2+ was 128 ± 4 nM and spontaneous elevations 
in endfoot Ca2+ did not exceed 500 nM (range: 179 nM to 496 nM; mean: 303 ± 10 nM; n 
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= 73 events from 13 endfeet).  However, in brain slices from SAH animals, we often 
observed high-amplitude spontaneous events (peak Ca2+, ≥500 nM; eHACSs) in addition 
to spontaneous Ca2+ increases that were similar in amplitude to those observed in un-
operated animals (peak Ca2+, <500 nM; “control-like events”).  Thus, after SAH, endfeet 
fell into one of two categories: (1) endfeet with spontaneous Ca2+ events that were all 
“control-like” in amplitude, i.e., peak Ca2+ <500 nM, or (2) endfeet with a combination of 
eHACSs and “control-like” spontaneous Ca2+ events.  χ2 analysis indicates an association 
between the incidence of endfeet exhibiting eHACSs and time (4 h, 2 d, 4 d) post-SAH 
(χ2 = 8.839, df = 2, p = 0.012).   For example, at the earliest time point (4 h SAH) only 
~27% of endfeet had eHACSs, whereas ~83% of endfeet were eHACSs-positive in brain 
slices from 2 d SAH animals (Fig. 1C).  The mean amplitude (~700 nM) and frequency 
of eHACSs were similar at all SAH time points (F[5, 83] = 0.81; ANOVA, p = 0.54, and  
F[5, 39] = 1.80; ANOVA, p = 0.14, respectively).  When compared with events from 
control animals, post hoc comparison of the means (Bonferroni) demonstrated that there 
was no change in the amplitude of “control-like” spontaneous Ca2+ events at any time-
points after SAH, irrespective of the presence or absence of eHACSs (p > 0.05 in each 
group, Table 1).  These data demonstrate that SAH leads to the time-dependent 





The inversion of NVC parallels the emergence of eHACSs after SAH 
We next examined whether the inversion of NVC followed a similar time-
dependent pattern of development as that of eHACSs after SAH.  In brain slices from 
control animals, EFS-evoked neuronal activation caused the anticipated NVC response: a 
rise in astrocyte endfoot Ca2+ followed by vasodilation of the adjacent arteriole (Fig. 2A; 
n = 6 arterioles, N = 6 animals).  Similar vasodilatory NVC responses were observed in 
all brain slices obtained from 4 h SAH animals (n = 6 arterioles, N = 5 animals).  
However, EFS-induced vasoconstriction (i.e. inversion of NVC) was observed in brain 
slices from animals at later SAH time-points.  Inversion of NVC peaked at 2 d SAH with 
100% of brain slices (n = 7 arterioles, N = 6 animals) exhibiting EFS-induced 
vasoconstriction, then steadily declined at later time-points (Fig. 2B,C).  One-way 
ANOVA demonstrated a main effect of time post-SAH on EFS-evoked changes in 
arteriolar diameter (F[6, 40] = 4.961, p = 0.0007).  Post hoc multiple comparisons of the 
means (Bonferroni) revealed significance at the 2 and 4 d SAH time-points (p = 0.001, 
0.01, respectively).  Although SAH influenced the polarity of EFS-induced vascular 
responses, evoked increases in endfoot Ca2+ in brain slices from SAH animals were 
similar to those in the control group (Table 2, F[6,39] = 0.52; ANOVA, p = 0.79).  There 
also was no difference in the mean arteriolar diameter before EFS between groups (F[6,40] 
= 1.74; ANOVA, p = 0.14).  In two instances, one at the 24 h and one at the 7 d SAH 
time-points, we observed opposing vascular responses in brain slices from the same 
animal, suggesting that inversion of NVC develops and resolves non-uniformly 
throughout brain cortex.  Consistent with our hypothesis that the emergence of eHACSs 
dictates the polarity of the neurovascular response after SAH, the time course of 
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inversion of NVC was remarkably similar to the time course of the emergence of 
astrocyte endfeet exhibiting eHACSs (Fig. 2D).   
To further explore causality between the emergence of eHACSs and inversion of 
NVC, we captured both phenomena in single continuous recordings (3 min recording of 
spontaneous activity followed by EFS) of brain slices obtained from 24 h SAH animals.  
Here, we chose to study the 24 h SAH time-point because approximately half of the brain 
slices from these animals exhibited normal NVC (EFS-induced vasodilation) while the 
remaining slices exhibited inversion of NVC (EFS-induced vasoconstriction).  As 
anticipated, endfeet in brain slices from 24 h SAH animals displayed either only “control-
like” spontaneous Ca2+ events (i.e. no eHACSs) or exhibited a combination of “control-
like” events and eHACSs during the initial 3 min of recordings capturing spontaneous 
Ca2+ events (Fig. 3A).  EFS-induced vasodilation (12 ± 4% increase in diameter, n = 4 
arterioles, N = 4 animals) occurred in all brain slices exhibiting only “control-like” 
spontaneous Ca2+ events (mean amplitude of spontaneous Ca2+ events: 284 ± 16 nM, 
range: 189-485 nM, 32 events in four brain slices from four animals, Fig. 3B).  
Conversely, inversion of NVC (EFS-induced vasoconstriction, 17 ± 7% decrease in 
diameter, n = 5 arterioles, N = 5 animals) was observed in all brain slices containing 
eHACSs-positive endfeet (71 events in 5 brain slices from 5 animals, Fig. 3B).  The 
presence or absence of eHACSs did not impact EFS-evoked increases in astrocyte 
endfoot Ca2+ or the overall frequency of spontaneous Ca2+ events (Fig. 3C,D; p = 0.46; 
two-tailed t test, p = 0.33; two-tailed t test, respectively).  In two cases, brain slices with 
endfeet exhibiting eHACSs also had endfeet where eHACSs were not observed along the 
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same arteriolar segment.  These results are consistent with the emergence of eHACSs 
causing inversion of NVC after SAH. 
 
Abolition of eHACSs restores vasodilatory responses in brain slices from SAH 
animals 
Release of Ca2+ from the ER underlies the generation of spontaneous Ca2+ events 
in astrocyte endfeet of healthy animals (Dunn et al., 2013).  To examine the role of ER 
Ca2+ release in the generation of eHACSs, cyclopiazonic acid (CPA), a selective 
sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) inhibitor, was used to deplete 
astrocyte ER Ca2+ stores.  In brain slices from control animals, CPA treatment (30 µM, 
25 min) abolished spontaneous endfoot Ca2+ events (Fig. 4A), as expected.  Importantly, 
CPA also abolished all spontaneous Ca2+ signals, including eHACSs, in brain slices from 
2 d SAH animals indicating that SAH-induced eHACSs are mediated via ER Ca2+ release 
(Fig. 4B).   
Using CPA to deplete ER Ca2+, we next examined whether the elimination of 
SAH-induced eHACS could restore vasodilatory responses typical of NVC.  However, 
because EFS-evoked vasodilation is also dependent on astrocyte endfoot ER Ca2+ release 
(Straub et al., 2006), we targeted two elements downstream of neuronal activation in the 
NVC signaling cascade (increased endfoot Ca2+ and elevated perivascular K+).  First, 
two-photon photolysis of caged Ca2+ was used to induce a focal (excitation volume ~1 
µm3) rise in endfoot Ca2+.  Consistent with EFS-induced vascular responses (Fig. 2), 
uncaging Ca2+ in astrocyte endfeet in the absence of CPA caused a similar amplitude 
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endfoot Ca2+ transient in all brain slices (Control: 436 ± 35 nM; SAH: 417 ± 32 nM p = 
0.47; two-tailed t test), but caused vasodilation in brain slices from control animals and 
vasoconstriction in brain slices from 2 d SAH animals.  Treatment of brain slices from 
control animals with CPA did not affect vasodilation induced by photolysis of caged Ca2+ 
in astrocyte endfeet (Fig. 4C, p = 0.243; two-tailed t test).  However, in brain slices from 
2 d SAH animals, CPA treatment (i.e., abolishing eHACSs) reversed Ca2+ uncaging 
responses from constriction to dilation (Fig. 4D, p < 0.0001; two-tailed t test).  In the 
presence of CPA, the amplitude of endfoot Ca2+ transients induced by uncaging Ca2+ 
were again similar between groups (Control: 365 ± 53 nM; SAH: 310 ± 50 nM, p = 0.83; 
two-tailed t test). These results indicate that abolishing eHACSs restored normal 
astrocyte-vascular signaling in brain slices from SAH animals (Fig. 4E). 
Modest increases in the extracellular/perivascular K+ concentration play an 
important role in astrocyte-to-smooth muscle communication during NVC (Filosa et al., 
2006; Girouard et al., 2010).  Typically, neurally-evoked increases in endfoot Ca2+ 
activate large-conductance Ca2+-activated K+ (BK) channels on astrocyte endfeet, causing 
an estimated 5-10 mM increase in perivascular K+ and vasodilation via activation of 
smooth muscle strong inwardly rectifying K+ (KIR) channels (Filosa et al., 2006; Girouard 
et al., 2010).  Previous studies have mimicked neurally-evoked endfoot K+ efflux by 
increasing the K+ concentration in the brain slice superfusate from 3 mM to 10 mM 
(Filosa et al., 2006; Girouard et al., 2010; Koide et al., 2012).  Here, we examined the 
effect of K+-induced changes in arteriolar diameter in brain slices obtained from control 
and 2 d SAH animals in the presence and absence of endfoot spontaneous Ca2+ events.  
Similar to the inversion of NVC, increasing extracellular K+ from 3 to 10 mM in brain 
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slices with intact astrocyte ER Ca2+ (i.e., endfeet exhibiting spontaneous Ca2+ events) 
caused arteriolar dilation in brain slices from un-operated animals and vasoconstriction in 
brain slices from 2 d SAH animals.  As with Ca2+ uncaging, abolishing spontaneous Ca2+ 
events with CPA (30 µM, 25 min) restored arteriolar dilation in response to 10 mM 
extracellular K+ in brain slices from 2 d SAH animals and had no effect on K+-induced 
vasodilation in brain slices from control animals (Fig. 4F, p < 0.0001; two-tailed t test, p 
= 0.56; two-tailed t test, respectively).  Thus, abolishing eHACSs restored vasodilatory 
responses in brain slices after SAH. 
 
Asymmetrical enlargement of perivascular astrocyte endfeet after SAH 
 Central nervous system (CNS) pathologies such as traumatic brain injury, 
ischemic stroke and SAH are associated with astrocyte hypertrophy and reactive gliosis 
(Murakami et al., 2011; Burda and Sofroniew, 2014).  To explore the impact of SAH on 
the ultrastructure of the gliovascular interface (i.e., astrocyte endfeet and parenchymal 
arterioles), we used TEM to image brain cortex from control, 2 d sham-operated and 2 d 
SAH model animals.  Astrocyte endfeet surrounding parenchymal arterioles from control 
and sham-operated animals exhibited a thin, uniform, sheath-like morphology (Fig. 5A).  
In contrast, perivascular endfeet of SAH animals exhibited regions of asymmetrical 
thickening that contained numerous subcellular organelles, including lysosomes (Fig. 
5A).  Lysosomes were observed in 12 of 16 endfeet after SAH, but were not observed in 
endfeet from control or sham-operated animals.  Remarkably, in 2 d SAH animals, the 
percentage of endfeet exhibiting asymmetrical hypertrophy (~81%, 13/16 endfeet) was 
similar to the percentage of endfeet exhibiting eHACS (~83 %; Fig. 1D).  Using a 
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threshold of 3-times the mean thickness of control endfeet (~690 nm), we determined that 
~17% of the arteriolar circumference is surrounded by an enlarged endfoot after SAH 
(Fig. 5C, Tukey, p < 0.0001 vs control, p = 0.0008 vs sham).  Interestingly, despite 
enlargement of endfoot processes, the distances measured between the endfeet and 
arteriolar smooth muscle (i.e., the perivascular space) in these samples were similar 
between groups (~70 nm, Fig. 5B, F[2,627] = 1.17; ANOVA, p = 0.31).  These results 
suggest a possible link between structural changes in perivascular endfeet after SAH and 
altered endfoot Ca2+ signaling (i.e. eHACSs). 
 
Discussion 
This study provides evidence that the emergence of high-amplitude spontaneous 
Ca2+ events within astrocyte endfeet underlies SAH-induced inversion of NVC.  High-
amplitude Ca2+ signals or “eHACSs” were absent in brain slices from un-operated control 
animals, and were present only in endfeet surrounding arterioles exhibiting inversion of 
NVC.  Further, abolishing eHACSs through pharmacologic depletion of ER Ca2+ restored 
typical vasodilatory responses to two elements involved in the NVC signaling cascade — 
increased endfoot Ca2+ and modest elevation of extracellular K+.  BK channels, localized 
to the endfoot membrane (Price et al., 2002), are the most likely Ca2+ sensor responsible 
for transducing eHACSs into a pathological vascular response.  Astrocyte BK channels 
are an important component of neurovascular communication (Filosa et al., 2006; 
Girouard et al., 2010; Koide et al., 2012) and contain auxiliary β4 subunits (Seidel et al., 
2011) conferring a high level of Ca2+-sensitivity to these channels (Horrigan and Aldrich, 
2002; Bai et al., 2011).  Thus, considering the Ca2+-sensitivity and large single channel 
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conductance of BK channels, it is likely that SAH-induced eHACSs cause a substantial 
increase in BK-mediated K+ efflux.  As the restricted perivascular space between endfeet 
and arteriolar myocytes is estimated to be less than 100 nm (Nagelhus et al., 1999) (see 
also, Fig. 5B), relatively small changes in the number of K+ ions would significantly 
impact the K+ concentration within the micro-domain surrounding parenchymal arterioles 
(Girouard et al., 2010).  Cerebral arteries are highly sensitive to changes in extracellular 
K+ (Knot et al., 1996; Zaritsky et al., 2000).  Modest increases in extracellular K+ (≤20 
mM) cause arteriolar dilation via activation of smooth muscle KIR channels (Knot et al., 
1996; Filosa et al., 2006; Girouard et al., 2010). However, larger increases (>20 mM) 
cause a depolarizing shift in the K+ equilibrium potential of smooth muscle that leads to 
enhanced Ca2+ entry through L-type voltage-dependent Ca2+ channels and arteriolar 
constriction (Knot and Nelson, 1998).  Our previous work indicates that SAH-induced 
inversion of NVC is a result of abnormally elevated basal perivascular K+ that, when 
combined with neurally-evoked K+ efflux, leads to smooth muscle membrane potential 
depolarization and a switch in the polarity of the vascular response from dilation to 
constriction (Koide et al., 2012).  We now demonstrate that altered spontaneous Ca2+ 
signaling in the form of eHACSs dictates the polarity of NVC after SAH.  These results 
are consistent with the concept that SAH-induced eHACSs enhance BK channel activity 
in the endfeet causing an increase in basal perivascular K+ and inversion of NVC. 
This work expands upon a growing body of research indicating that SAH-induced 
cortical infarcts and poor clinical outcome are due to disruption of blood flow within the 
brain micro-circulation (Dreier et al., 2002; Ishiguro et al., 2002; Rabinstein et al., 2005; 
Pluta et al., 2009; Nystoriak et al., 2011; Ostergaard et al., 2013).  Microvasculature 
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dysfunction after SAH would be predicted to cause cerebral infarction in relatively small, 
spatially-defined regions due to the paucity of collaterals within the brain parenchyma 
(Nishimura et al., 2007).  Roughly 60% of patients exhibit diffuse ischemic brain lesions 
following SAH (Hijdra et al., 1986).  Further, it has been suggested that the mechanism 
underlying diffuse brain injury differs from that which causes cell death near the site of 
aneurysm rupture (Rabinstein et al., 2005).  While neuronal viability was not directly 
examined in the current study, the inversion of NVC likely precedes substantial cell death 
or neuronal injury after SAH as EFS-evoked changes in endfoot Ca2+ were comparable in 
brain slices from control and SAH animals.  Previous studies have also shown altered ion 
channel function and/or expression in vascular smooth muscle cells following exposure 
to the blood component, oxyhemoglobin (Ishiguro et al., 2005; Wellman, 2006; Link et 
al., 2008).  Thus, it is possible that ischemic events following SAH result from the 
combined effects of inversion of NVC and other actions of SAH, including a direct 
increase in arteriolar smooth muscle contractility (Nystoriak et al., 2011).  Future studies 
will be required to establish the contribution of pathological astrocyte Ca2+ signaling and 
inversion of NVC in the development of delayed cerebral ischemia following SAH. 
Astrocytes typically respond to CNS perturbations (including SAH) by 
undergoing a characteristic hypertrophy known as reactive gliosis (Murakami et al., 
2011; Burda and Sofroniew, 2014).  Although the morphological and molecular changes 
associated with reactive gliosis are well-described (Sofroniew, 2009), the functional 
consequences remain unclear.  Recent in vivo measurements of astrocyte Ca2+ signaling 
using a mouse model of familial Alzheimer’s disease demonstrated a “hyperactive” Ca2+ 
signaling phenotype in reactive astrocytes (Delekate et al., 2014).  Importantly, the 
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aberrant Ca2+ signals present in endfeet were associated with spontaneous 
vasoconstrictions of the neighboring arterioles.  These data provide an interesting parallel 
between the phenomena we observe after SAH (i.e. emergence of endfeet exhibiting 
eHACSs, inversion of NVC, and asymmetrical endfoot hypertrophy) and the functional 
alterations observed in a mouse model of Alzheimer’s disease.   
The results from our TEM studies demonstrated asymmetrical enlargement of 
astrocyte endfeet following SAH.  While endfoot swelling has been suggested to 
compress cerebral micro-vessels after SAH (Ostergaard et al., 2013), it is unlikely that 
the endfoot enlargement we are reporting directly causes arteriolar narrowing, as we 
detected no change in arteriolar diameter prior to EFS at any time-points after SAH 
(Table 2).  Further, we found no change in the width of the perivascular space using TEM 
(Fig. 5).  However, these static TEM measurements of the perivascular space were made 
using perfusion-fixed tissue susceptible to spacing artifacts.  It is also important to 
consider that the perivascular space surrounding parenchymal arterioles provides a 
critical and dynamic conduit for the exchange of CSF with brain interstitial fluid (ISF) 
(Iliff et al., 2012; Iliff et al., 2013).  Considering previous work showing that increased 
arousal decreases ISF-CSF fluid exchange (Xie et al., 2013), it is possible that increases 
in arteriolar diameter during vasodilatory NVC coincide with decreases in perivascular 
volume.  Conversely, vasoconstrictive NVC would be predicted to increase perivascular 
volume and enhance ISF-CSF exchange.  Thus, it is conceivable that the inversion of 
NVC after SAH represents an adaptive response promoting the clearance of bloody CSF. 
Our data indicate that SAH-induced high-amplitude Ca2+ signaling events, in the 
form of eHACSs, result from increased Ca2+ release from subcellular ER stores (Fig. 4).  
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However, the cellular basis underlying the enhanced release of Ca2+ after SAH remains to 
be determined.  An increase in ER Ca2+ load, or increased expression/sensitivity of IP3 
receptors could potentially contribute to the emergence of eHACSs after SAH.  However, 
increased production of IP3 could also underlie SAH-induced eHACSs.  It is generally 
appreciated that endfoot Ca2+ signals result from activation of Gq-coupled receptors and 
the production of IP3 (Fiacco and McCarthy, 2006; Straub et al., 2006).  Astrocytes 
express a multitude of Gq-coupled receptors that could play a role in the generation of 
eHACSs.  Previously, purinergic signaling was been implicated in the hyperactive Ca2+ 
signaling phenotype observed in reactive astrocytes in an Alzheimer’s disease model 
(Delekate et al., 2014).  Further, the Gq-coupled purinergic receptors, P2Y2 and P2Y4, are 
expressed in astrocyte endfeet (Simard et al., 2003), and up-regulation of purinergic 
signaling has been implicated after SAH (Kasseckert et al., 2013).  Interestingly, 
astrocyte lysosomes are capable of ATP release (Zhang et al., 2007) and we observed 
organelles appearing to be lysosomes in endfeet of SAH, but not control animals (Fig. 
5A).  There is strong evidence from Alzheimer’s disease models that astrocyte lysosomes 
are involved in the clearance of β-amyloid plaques (Funato et al., 1998; Wyss-Coray et 
al., 2003).  Considering the distribution of red blood cells and blood products along the 
parenchymal arteriolar walls after SAH (Koide et al., 2012), the presence of enlarged 
endfeet containing lysosomes in our TEM samples may indicate a role for astrocytes in 
the clearance of extravascular blood components.  However, future studies are necessary 
to determine the role of reactive astrogliosis and purinergic signaling in the development 
of SAH-induced eHACSs and inversion of NVC.   
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In summary, our results indicate a causal link between the emergence of high-
amplitude spontaneous Ca2+ events in astrocyte endfeet (i.e. eHACSs) and SAH-induced 
inversion of NVC.  These findings identify astrocytes as a key player in SAH-induced 
disruption of cortical blood flow.  Further work targeting the impact of SAH on astrocyte 
function may lead to the development of new therapeutic strategies to treat brain 
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Figure 2-1.  Emergence of endfoot high-amplitude Ca2+ signals (eHACS) following 
SAH 
A, (Top) Images of parenchymal arterioles and surrounding astrocyte endfeet in brain 
slices obtained from control (left) and 2 d SAH model rats (right).  The red dashed lines 
on grey-scale IR-DIC images depict intraluminal diameter. Overlapping pseudocolor-
mapped fluorescent Ca2+ images of endfeet were simultaneously acquired using two-
photon microscopy.  Scale bars are 10 µm.  (Bottom) Time-lapse images from the area 
within the yellow dotted box in top panels.  B, Spontaneous Ca2+ activity recorded from 
1.2 x 1.2 µm regions of interest shown in the black squares in panel A.  Black arrowheads 
indicate the spontaneous Ca2+ events depicted in the time-lapse series of A.  Red circles 
indicate eHACSs (peak Ca2+ levels ≥500 nM).  C, Number of endfeet with and without 
eHACSs (red and gray dots, respectively) observed in control (N = 8 animals) and SAH 
model animals (N = 6-8 animals per time point).  χ2 analysis indicates an association 
between the incidence of endfeet exhibiting eHACSs and time (4 h, 2 and 4 d) post-SAH 














Figure 2-2.  The inversion of NVC parallels the emergence of eHACSs in brain slices 
from SAH model animals. 
A,B,  EFS-induced changes in arteriolar diameter and astrocyte endfoot Ca2+ in brain 
slices from control (A) and 2 d SAH animals (B).  (Top) IR-DIC images with 
simultaneously acquired pseudo-colored Ca2+ fluorescence maps showing arteriolar 
diameter (depicted in red dashed line) and astrocyte endfoot Ca2+ before and after EFS.  
Scale bars are 10 µm.  (Bottom) EFS-evoked changes in endfoot Ca2+ and arteriolar 
diameter corresponding to the above images.  Although EFS caused a similar increase in 
astrocyte endfoot Ca2+ (black traces), it was associated vasodilation (green trace) in brain 
slices from control animals and vasoconstriction (red trace) in brain slices from 2 d SAH 
animals.  C, Summary of EFS-induced arteriolar responses in brain slices from control 
and SAH model animals.  Black lines represent the mean change in diameter per study 
group (n = 6-8 arterioles from 4-6 animals per group).  *p < 0.05; ** p < 0.01 (one-way 
ANOVA, followed by Bonferroni’s post hoc test). D, Relationship between the 
percentage of endfeet with eHACSs and percentage of arterioles exhibiting inversion of 













Figure 2-3.  The presence of eHACSs is associated with inversion of NVC. 
A, Continuous in tandem recordings of spontaneous Ca2+ events and EFS-evoked changes 
in arteriolar diameter and astrocyte endfoot Ca2+ from brain slices of 24 h SAH animals.  
In brain slices with endfeet lacking eHACSs (left), EFS triggered a rise in endfoot Ca2+ 
and vasodilation of the adjacent arteriole. However, when eHACSs were present in the 
surrounding endfeet (right), a similar EFS-evoked rise in endfoot Ca2+ elicited 
vasoconstriction (i.e., inversion of NVC).  B, Summary of EFS-induced changes in 
arteriolar diameter in brains slices with and without endfeet exhibiting eHACSs (n = 4 or 
5 arterioles, N = 4 or 5 animals).  ** p < 0.01 (two-tailed t test).  C, Summary of the EFS-
induced rise in endfoot Ca2+ in brain slices with or without eHACSs (n = 7-11 endfeet, N 
= 4-5 animals).  D, Summary of the frequency of spontaneous Ca2+ events in brain slices 








Figure 2-4.  Abolishing eHACSs restores arteriolar dilation in brain slices from 
SAH animals 
A,B,  Depletion of intracellular Ca2+ stores with cyclopiazonic acid (CPA, 30 µM) 
treatment abolished spontaneous Ca2+ events in astrocyte endfeet from control and 2 d 
SAH animals (n = 5-6 endfeet per group, N = 4 animals per group).  C,D,  Changes in 
endfoot Ca2+ and arteriolar diameter evoked by photolysis (uncaging) of caged-Ca2+ in 
brain slices from control (C) and 2 d SAH animals (D), with (top) or without spontaneous 
Ca2+ signals (bottom), i.e., ± CPA treatment.  E, Summary data depicting percent change 
in arteriolar diameter induced by Ca2+ uncaging in the presence or absence of CPA (n = 4 
arterioles per group, N = 3-4 animals per group).  F,  Summary data depicting percent 
change in diameter evoked by increasing extracellular K+ in ACSF superfusate from 3 
mM to 10 mM in the presence or absence of CPA (n = 6-10 arterioles per group, N = 4-5 








Figure 2-5.  Astrocyte endfeet with asymmetrical hypertrophy encase parenchymal 
arterioles following SAH 
A,  (Top) Low-magnification TEM images of parenchymal arterioles in cerebral cortices 
obtained from 2 d sham-operated and 2 d SAH model animals.  Astrocyte endfeet are 
highlighted in yellow.  (Bottom) High-magnification images of the arteriolar wall 
(endothelial and smooth muscle cell layers) as well as the surrounding astrocyte endfoot 
from within the black boxes.  Lysosomes (round electron dense structures) were only 
observed in areas of enlarged endfeet from SAH animals.   B, Distance between astrocyte 
endfeet and arteriolar smooth muscle (i.e., width of the perivascular space) measured at 
10 random equally spaced locations along the arteriolar circumference. (n = 16-27 
arterioles per group, N = 4-5 animals per group).  C, Summary of endfoot hypertrophy.  
Data are presented as the percentage of the arteriolar circumference surrounded by an 
enlarged endfoot (i.e., >3 times the mean thickness of control endfeet) (n = 16-27 
arterioles per group, N = 4-5 animals per group).  ** p < 0.01 vs control, ## p < 0.01 vs 




Table 2-1.  Impact of SAH on spontaneous Ca2+ events in astrocyte endfeet 












eHACSs        
Basal endfoot Ca2+ 
(nM) 
 
128 ± 4 
 
121 ± 3 
 ns 
125  ± 7 
 ns 
134  ± 
19 
 ns 
128 ± 7 
 ns 
121 ± 6 
 ns 
125 ± 4 
 ns 
































































n, N (endfeet, 
animals) 13, 8 11, 4 6, 5 2, 7 7, 6 7, 5 11, 5 
Endfeet with 
eHACSs        
Basal endfoot Ca2+ 
(nM) 
 
- 124 ± 7  
128  ± 3 
NS 
127  ± 4  
NS 
129 ± 4  
NS 
131 ± 6  
NS 
131 ± 4  
NS 
Range of Ca2+ event 
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n, N (endfeet, 
animals) 0, 8 4, 4 7, 5 10, 7 10, 6 9, 5 4, 5 
82 
 
All Endfeet        
Total spontaneous 
Ca2+ events 73 81 72 94 78 63 70 
 
One-way analysis of variance (ANOVA) followed by Bonferroni test were used for the post hoc 
comparison of multiple groups.  ns: not statistically different (p > 0.05) compared to control 
group in endfeet without eHACSs.  NS: not statistically different (p >0.05) compared to 4 h SAH 





Table 2-2.  Impact of SAH on NVC 











Brain slices with intact NVC (i.e. arteriolar dilation) 
Arteriolar diameter  




0.8 5.0 ± 0.6 - 6.8 
8.3 ± 
0.8 6.1 ± 0.7 
Endfoot Ca2+ 
before EFS (nM) 
139 ± 
19 127 ± 8 137 ± 8 - 137 128 ± 6 123 ± 8 
Endfoot Ca2+ 




30 404 ± 32 - 388 
378 ± 
38 413 ± 27 
n, N (slices, 
animals) 6, 6 6, 5 3, 4 0, 5 1, 5 4, 6 5, 4 
Brain slices with inversion of NVC (i.e. arteriolar constriction) 
Arteriolar diameter  








before EFS (nM) - - 128 ± 6 128 ± 4 135 ± 3 122 ± 5 122 
Endfoot Ca2+ 







n, N (slices, 






Chapter 3: Purinergic signaling triggers endfoot high-amplitude Ca2+ 
signals and causes inversion of neurovascular coupling after 
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Neurovascular coupling (NVC) is the process whereby astrocytes match focal increases 
in neuronal activity with local arteriolar dilation by releasing vasoactive substances (e.g. 
K+ ions) from perivascular endfeet.  Previously, we demonstrated that an emergence of 
endfoot high-amplitude Ca2+ signals (eHACSs) after subarachnoid hemorrhage (SAH) 
caused a pathological shift in NVC from vasodilation to vasoconstriction.  Extracellular 
purine nucleotides (e.g. ATP) can trigger astrocyte Ca2+ oscillations, and may be elevated 
following SAH.  Here, we imaged Fluo-4-loaded rat brain slices using two-photon 
fluorescence microscopy to determine the role of purinergic signaling in the generation of 
SAH-induced eHACSs and inversion of NVC.  We report that broad-spectrum inhibition 
of purinergic (P2) receptors using suramin selectively blocked eHACSs and restored 
vasodilatory NVC in brain slices from SAH animals.  Importantly, eHACSs were 
selectively abolished using a cocktail of inhibitors targeting Gq-coupled P2Y receptors.  
Further, activation of P2Y receptors in brain slices from un-operated animals triggered 
high-amplitude Ca2+ events resembling eHACSs and disrupted NVC.  Neither 
tetrodotoxin nor bafilomycin A1 had an effect on eHACSs suggesting that purine 
nucleotides are not released by ongoing neurotransmission after SAH.  Together, these 
results indicate that purinergic signaling via P2Y receptors contributes to SAH-induced 





Aneurysmal subarachnoid hemorrhage (SAH) is associated with substantial 
morbidity and mortality against which current therapeutic options have limited efficacy 1.  
The development of multifocal cortical infarcts days to weeks after the initial bleed is a 
frequent complication jeopardizing the survival and long-term outcome of SAH patients 
2-4.  Perfusion deficits within brain cortex are generally appreciated to contribute to the 
widespread ischemia following SAH 5, 6.  However, the signaling pathways linking SAH 
to micro-vascular dysfunction are not fully understood. 
Intra-cerebral (parenchymal) arterioles represent a significant bottleneck to 
cortical perfusion, and are regulated extrinsically by surrounding astrocyte endfeet 7, 8.  In 
the healthy brain, increased neuronal activity triggers a rise in astrocyte endfoot Ca2+ 
causing the release of vasoactive substances (e.g. K+ ions) into the restricted perivascular 
space and parenchymal arteriolar dilation 9.  This functional hyperemic response, also 
referred to as neurovascular coupling (NVC), ensures adequate delivery of O2 and other 
nutrients to areas of the brain with increased metabolic demand.  Previously, we 
demonstrated that an emergence of spontaneous endfoot high-amplitude Ca2+ signals 
(eHACSs) caused inversion of NVC from vasodilation to vasoconstriction in brain slices 
obtained from SAH model animals 10, 11.  A shift in NVC from vasodilation to 
vasoconstriction may contribute to the development of focal ischemia after SAH by 
restricting blood flow to active brain regions.  However, the cellular basis underlying the 
generation of eHACSs after SAH has not been determined. 
87 
 
The goal of this study was to determine whether enhanced purinergic signaling 
underlies the generation of eHACSs and inversion of NVC after SAH.  Astrocytes 
broadly express both ionotropic and metabotropic purinergic receptors that trigger a rise 
in intracellular Ca2+ when activated 12, 13.  Increased signaling via extracellular purine 
nucleotides (e.g. ATP) is common after brain injury; including aneurysmal SAH 12, 14 and 
studies have reported elevated levels of ATP in the cerebral spinal fluid (CSF) after SAH 
14, 15.  Interestingly, purinergic signaling has also been reported to cause aberrant 
astrocyte Ca2+ elevations that are associated with vascular instability and disrupted NVC 
in a mouse model of Alzheimer’s disease 16, 17.   
Here, using combined infrared-differential interference contrast (IR-DIC) and 
two-photon fluorescence microscopy, we report that inhibition of Gq-coupled P2Y 
purinergic receptors abolished eHACSs and restored vasodilatory NVC in brain slices 
obtained from SAH model animals.  However, block of P2Y receptors did not affect 
astrocyte Ca2+ signaling in brain slices from control animals and inhibition of ionotropic 
P2X receptors did not alter Ca2+ signaling in either the control or SAH groups. Further, 
we show that activation of P2Y receptors in brain slices from control animals mimicked 
SAH by triggering high-amplitude endfoot Ca2+ events resembling eHACSs and 
disrupting NVC responses. This work identifies astrocyte P2Y receptors as an important 
component of SAH pathology and a novel potential therapeutic target in the treatment of 
micro-vascular dysfunction following cerebral aneurysm rupture.  
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Materials and Methods 
Rat SAH model.  The double-injection cisterna magna model was used to mimic 
aneurysmal SAH, as previously described 10, 18.  Briefly, autologous, unheparanized 
arterial blood (0.5 mL drawn from the tail artery) was injected into the cisterna magna of 
isoflurane-anesthetized Sprague-Dawley rats (male, 10-12 weeks old, Charles River 
Laboratories).  This surgical procedure was repeated following a 24 h recovery period.  
SAH model animals were euthanized at 2 d (48 h) following the first injection of 
subarachnoid blood.  The 2 d SAH time point was chosen because we previously found 
that at this time point the vast majority of astrocyte endfeet (~80%) exhibit eHACSs; 
defined as spontaneous (i.e., non-stimulated) events with endfoot Ca2+ exceeding 500 nM 
11.  The 2 d SAH time-point also coincided with the highest percentage (100%) of brain 
slices exhibiting inversion of NVC. Un-operated animals served as the control group.  All 
procedures were conducted in accordance with the Guide for the Care and Use of 
Laboratory Animals (eighth edition, 2011) and followed protocols approved by the 
Institutional Animal Care and Use Committee at the University of Vermont.  
Simultaneous measurement of arteriolar diameter and astrocyte endfoot Ca2+ in cortical 
brain slices.   
Brain slice preparation:  Animals were euthanized by decapitation while under deep 
anesthesia with pentobarbital (60 mg/kg).  Coronal brain slices (160 µm thick) were cut 
in ice-cold, aerated (5 % CO2/95 % O2) artificial cerebral spinal fluid (ACSF) using a 
Leica VT1000S vibratome.  Brain slices were incubated with the fluorescent Ca2+ 
indicator, Fluo-4 AM (10 µM) for 1.5 h at 29 °C in aerated ACSF containing 0.04 % 
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pluronic acid.  Under these conditions, Fluo-4 preferentially loads into astrocytes 19.  
After incubating with Fluo-4 AM, brain slices were rinsed and maintained in aerated 
ACSF at room temperature prior to imaging.  
Simultaneous recordings of arteriolar diameter and endfoot Ca2+:  A BioRad Radiance 
multi-photon imaging system (excitation wavelength: 820 nm, fluorescent bandpass 
filter: 575/150 nm, sampling frequency ~1 Hz) coupled to a Coherent Chameleon Ti-
Sapphire laser was used to simultaneously obtain infrared-differential interference 
contrast (IR-DIC) and fluorescent brain slices images.  Arteriolar segments (cortical layer 
2/3, middle cerebral artery territory) that were surrounded by fluo-4-loaded endfeet were 
chosen for study.  Spontaneous endfoot Ca2+ signals were recorded in the absence of 
stimulation.  NVC was initiated using electrical field stimulation (EFS; 50 Hz, 0.3 ms 
alternating square pulse, 3 s duration) to trigger neuronal action potentials 10, 11.  
Throughout all recordings, brain slices were continually superfused with aerated ACSF 
(32-34 °C) containing the thromboxane A2 analog, 9,11 di-dideoxy-11α,9α-
epoxymethanoprostaglandin F2α (U46619, 100 nM) to induce an intermediate level of 
arteriolar tone.  Ionomycin (10 µM) and CaCl2 (20 mM) were added to the bath at the end 
of each experiment to obtain maximal fluorescence. 
Analysis of arteriolar diameter:  Intraluminal arteriolar diameter was measured from IR-
DIC images at 3 evenly spaced points along a 10 µm length of segment exhibiting the 
greatest diameter change to EFS.  Diameter change is expressed as the percent increase or 
decrease from baseline (determined from 10 s prior to EFS and averaged for the 3 points 
of measurement).  Diameters were measured manually using custom software, SparkAn, 
written by Dr. Adrian D. Bonev, at the University of Vermont (Burlington, VT).  
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Analysis of endfoot Ca2+:  A region of interest (ROI, 1.2 µm x 1.2 µm) was placed within 
an endfoot that was either: 1) adjacent to the arteriolar segment used to measure diameter 
during EFS or 2) exhibiting spontaneous Ca2+ events in the absence of stimulation.  
Spontaneous Ca2+ events were defined by the following criteria: 1) ≥ 30 % increase in 
fluorescent intensity for at least 2 consecutive images, and 2) multiple events during a 4 
min recording period 11.  Endfoot Ca2+ concentrations were estimated using the maximal 
fluorescence method 20, 21. 
Statistical analysis:  Data are expressed as mean ± SEM (n: the number of observations, 
N: the number of animals). Student’s two-tailed paired t test was used for comparisons 
between two groups. 
Reagents:  U46619 and ionomycin were obtained from Calbiochem (EMD Millipore, 
Chicago, IL).  Fluo-4 AM and pluronic acid were obtained from Invitrogen (Life 
Technologies, Eugene, OR).  All P2 receptor antagonists were obtained from Tocris 
(Bristol, United Kingdom).  All other reagents were purchased from Sigma-Aldrich (St. 
Louis, MO). The composition of ACSF (in mM) was: 125 NaCl, 3 KCl, 18 NaHCO3, 
1.25 NaH2PO4, 1 MgCl2, 2 CaCl2, 5 glucose, and 0.4 ascorbic acid.   
 
Results!
Purinergic receptor inhibition abolishes SAH-induced eHACSs 
The role of purinergic signaling in the SAH-induced generation of astrocyte 
endfoot high amplitude Ca2+ signals (eHACSs) was explored in brain slices using the 
broad-spectrum purinergic receptor antagonist, suramin (100 µM)  (Fig. 1).  In brain 
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slices from control animals, spontaneous Ca2+ signals with amplitudes of less than 500 
nM were observed in Fluo-4-loaded endfeet using two-photon imaging.  Suramin had no 
effect on the amplitude (Fig. 1A, B) or frequency (0.019 ± 0.002 Hz vs 0.018 ± 0.001 Hz, 
two-tailed paired t test, p = 0.73) of endfoot Ca2+ signals in control animals.  In brain 
slices from SAH model animals, endfeet exhibited a mix of “control-like” Ca2+ signals 
(amplitudes < 500 nM) and high amplitude (> 500 nM) Ca2+ signals “eHACSs” as 
previously described 10, 11. Suramin treatment of brain slices from SAH animals nearly 
abolished eHACSs (Fig. 1B, C), but did not affect lower amplitude “control-like” events 
or the overall frequency of spontaneous Ca2+ signals (0.023 ± 0.005 Hz vs 0.025 ± 0.004 
Hz, two-tailed paired t test, p = 0.85).  In the presence of suramin, the mean amplitude of 
endfoot spontaneous Ca2+ signals was comparable between control and SAH groups (Fig. 
1D).  These results suggest that purinergic signaling is involved in SAH-induced 
eHACSs, but not “control-like” endfoot Ca2+ events.   
Suramin restores vasodilatory NVC after SAH 
As the emergence of eHACSs has been linked to inversion of NVC after SAH 10, 
11, we examined whether disruption of eHACSs with suramin could restore vasodilatory 
NVC in brain slices from SAH animals.  In the absence of suramin, generation of 
neuronal action potentials using EFS caused parenchymal arteriolar constriction in 100 % 
of SAH brain slices (n = 7/7, N = 6) (Fig. 2A).  Remarkably, suramin restored arteriolar 
dilation to EFS in the majority of brain slices (n = 6/7, N = 6) (Fig. 2B).  Suramin, 
however, did not alter the amplitude of EFS-evoked endfoot Ca2+ transients (Fig. 2C) or 
arteriolar diameter before EFS (6.5 ± 1.1 µm before suramin vs 6.2 ± 1.0 µm after 
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suramin, two-tailed paired t test, p = 0.53).  These data demonstrate inversion of NVC 
after SAH is dependent upon purinergic signaling and the presence of eHACSs in 
astrocyte endfeet surrounding parenchymal arterioles.   
P2Y receptors mediate SAH-induced eHACSs 
Purinergic (P2) receptors are broadly divided into 2 classes: ligand-gated, Ca2+-
permeable ion channels (i.e., P2X receptors), and metabotropic G-protein coupled (P2Y) 
receptors 22.  P2X receptors and P2Y receptors can be distinguished using α, β 
methylene-ATP (α, β-meATP), an ATP analog that rapidly desensitizes P2X, but not P2Y 
receptors 23.  To determine if Ca2+ influx through P2X receptors contributes to SAH-
induced eHACSs, spontaneous endfoot Ca2+ signals were recorded in brain slices from 
SAH animals before and after a 25 minute application of α, β-meATP (10 µM).  
Treatment with α, β-meATP had no effect on the incidence of eHACSs or on the overall 
frequency of endfoot Ca2+ signals (Fig. 3A-C), suggesting that P2X receptors are not 
involved in the generation of eHACSs after SAH.   
To examine the involvement of P2Y receptors in SAH-induced eHACSs, brain 
slices from SAH animals were treated with a cocktail of inhibitors targeting Gq-coupled 
P2Y receptors.  The components of this mix of P2Y receptor inhibitors included 
selective: P2Y1 (MRS 2179, 30 µM), P2Y2 (AR-C 118925XX, 10 µM), P2Y6 (MRS 
2578, 30 µM), and P2Y11 (NF 340, 30 µM) receptor antagonists 24-26.  This combination 
of P2Y inhibitors blocked eHACSs, but did not alter “control-like” events or the overall 
frequency of spontaneous Ca2+ signals (Fig. 3 D-F).   Interestingly, treatment of SAH 
brain slices with the PLC inhibitor, U73122 (30 µM, 30 min) abolished both SAH-
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induced eHACSs and all “control-like” events (n = 5, N = 3).  Spontaneous endfoot Ca2+ 
signals were also abolished by U73122 in brain slices from un-operated control animals 
(n = 7, N = 3), however, the inactive analog, U73343 (30 µM, 30 min), was without effect 
(n = 5, N = 4).  Together, these data indicate that Gq-coupled P2Y receptor signaling 
contributes to the generation of SAH-induced eHACSs and that non-purinergic Gq-
coupled receptors mediate “control-like” endfoot Ca2+ signals.   
Activation of P2Y receptors in brain slices from control animals mimics SAH 
We next sought to determine whether pharmacologic activation of P2Y receptors 
could mimic SAH in brain slices from un-operated animals.  To obviate the potentially 
confounding effects mediated by P2X receptors, brain slices were pre-treated with α, β-
meATP (10 µM, 25 min) to desensitize P2X receptors. In the presence of α, β-meATP, 
Ca2+ signals in endfeet from control animals were unaltered (i.e., all peaks <500 nM).  
However, subsequent treatment of brain slices with the non-hydrolyzable ATP analog, 
ATPγS (3 µM), to activate P2Y receptors triggered the emergence of high amplitude Ca2+ 
signals that were comparable to SAH-induced eHACSs (Fig. 4A-C).  These data suggest 
that functional P2Y receptors are present on astrocyte endfeet in healthy control animals 
and that activating these receptors generates Ca2+ signals resembling SAH-induced 
eHACSs.  Importantly, this pharmacological approach to activate P2Y receptors also 
caused a marked disruption of NVC in brain slices of control animals. In the presence of 
α, β-meATP (10 µM, 25 min), focal activation of neurons using EFS caused the 
anticipated arteriolar dilation in 100% of brain slices (n = 5/5, N = 4) (Fig. 4D).  
However, subsequent treatment with ATPγS (3 µM, 10 min) to activate P2Y receptors, 
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caused inversion of NVC (i.e., EFS-induced vasoconstriction) in 2 of 5 brain slices and 
attenuated the vasodilatory responses in the other 3 brain slices (Fig. 4D).  There was no 
effect of ATPγS on the amplitude of the EFS-evoked endfoot Ca2+ transients (Fig. 4E), or 
on arteriolar diameter before EFS (6.1 ± 0.9 µm before ATPγS vs 6.2 ± 0.9 µm after 
ATPγS, two-tailed paired t test, p = 0.64).  These data indicate that P2Y receptor-
mediated Ca2+ elevations in astrocyte endfeet can mimic SAH to disrupt NVC in brain 
slices from healthy control animals.   
SAH-induced eHACSs occur independent of neurotransmitter release 
 Neuronal release is one potential source of extracellular purine nucleotides (e.g. 
ATP) that could impact endfoot Ca2+ signaling after SAH 12.  To assess the contribution 
neurotransmitter release on eHACSs, tetrodotoxin (TTX, 3 µM, 20 min), an inhibitor of 
voltage-dependent Na+ channels, was used to block neuronal action potentials in brain 
slices from SAH animals 10.  Tetrodotoxin had no effect on the occurrence of eHACSs, 
the mean amplitude of Ca2+ events, or the frequency of Ca2+ events (Fig. 5A-C), 
suggesting that neuronal action potentials are not required for the generation of the P2Y 
receptor-mediated eHACSs.  These results, however, do not rule out the possibility that 
quantal (i.e., action potential-independent) neurotransmitter release or vesicular-mediated 
gliotransmitter release underlies the emergence of eHACSs after SAH. 
To determine whether vesicular release of purine nucleotides mediates SAH-
induced eHACSs, brain slices from SAH animals were treated with bafilomycin A1 (4 
µM), a vacuolar H+-ATPase inhibitor (Fig 5 D-G).  Bafilomycin depletes both neuronal 
and astroglial vesicles of transmitter and has been shown to inhibit Ca2+ signals in the 
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fine processes of hippocampal astrocytes 27-29.  Brain slices were exposed to bafilomycin 
for 4 h at room temperature prior to imaging.  Vehicle-treated (DMSO: 1:1000 dilution in 
ACSF) brain slices served as time controls for these experiments.  Bafilomycin had no 
effect on eHACSs, the mean amplitude of events, or frequency of events compared to 
time controls (Fig. 5D-F).  However, bafilomycin-treated slices failed to respond to EFS 
with a rise in endfoot Ca2+ (Fig. 5G) indicating that bafilomycin had successfully 
depleted vesicles of neurotransmitter.  Together, these results suggest that neither local 
neurotransmission nor astroglial vesicular release underlie purinergic receptor activation 
leading to SAH-induced eHACSs. 
 
Discussion 
 This study provides evidence that Gq-coupled P2Y purinergic receptor signaling 
underlies the emergence of endfoot high amplitude Ca2+ signals (eHACSs) and the 
inversion of NVC in brain slices from SAH animals.  The following observations are 
consistent with this novel finding: 1) broad-spectrum inhibition of purinergic P2 
receptors with suramin blocked eHACSs and restored vasodilatory NVC after SAH; 2)  
desensitization of Ca2+-permeable P2X receptors had no effect on the incidence of 
eHACSs; 3) SAH-induced eHACSs were abolished using a combination of inhibitors 
targeting Gq-coupled P2Y1, P2Y2, P2Y6 and P2Y11 receptors; 4) activation of P2Y 
receptors in brain slices from un-operated control animals mimicked SAH by triggering 
high-amplitude endfoot Ca2+ events and disrupting NVC.  These data identify astrocyte 
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purinergic receptor signaling as an important contributor to SAH-induced micro-vascular 
dysfunction and impaired NVC. 
In brain slices from SAH animals, the emergence of high amplitude spontaneous 
Ca2+ signals in astrocyte endfeet has been linked to increased activity of endfoot large-
conductance Ca2+-activated (BK) K+ channels, increased perivascular K+ and inversion of 
NVC 10, 11.  Here, we show activation of Gq-coupled P2Y receptors underlies the 
emergence of SAH-induced eHACSs.  Astrocytes express a variety of P2Y receptor 
subtypes that can be activated by multiple ligands found in purine/pyrimidine catabolic 
pathways (e.g. ATP, ADP, UTP, UDP) 12, 13.   As shown in figures 1 and 2, the broad-
spectrum P2 receptor antagonist, suramin 22, blocked eHACSs and restored NVC after 
SAH without affecting normal astrocyte Ca2+ signaling. Aside from acting as a purinergic 
antagonist, suramin has been shown to have a number of additional effects, including 
interference with receptor/G-protein coupling, inhibition of DNA and RNA polymerases 
and inhibition of growth factor binding 22, 30. Suramin has been used for nearly a century 
as a treatment for the initial phase of African trypanosomisis, commonly referred to as 
sleeping sickness 31 and has been studied as a treatment of high-grade glioma 32 and 
prostate cancer 33.  Our data using a combination of reagents targeting P2Y1, P2Y2, P2Y6 
and P2Y11 receptors (Fig. 3) indicate that the beneficial effects of suramin after SAH (i.e., 
block of eHACSs and rescue of vasodilatory NVC) are due to inhibition of P2 receptors, 
rather than off-target effects. Interestingly, Naviaux et al. have recently reported that 
suramin, through actions on purinergic signaling, can alleviate autism-like behaviors in a 
mouse model of autism spectrum disorder 34.  Further, P2Y receptor-mediated disruption 
of astrocyte Ca2+ signaling and impaired NVC have been observed in mouse models of 
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Alzheimer’s disease 16, 17. Considering the dire need for better therapeutic options for 
patients following aneurysmal SAH 1, 35, future in vivo studies targeting P2Y receptors 
using SAH models are warranted.  
  P2Y receptors are activated by a number of endogenous ligands, including ATP.  
Consistent with a role of extracellular ATP in the generation of SAH-induced eHACSs, 
elevated levels of ATP have been reported in CSF after SAH 14, 15, and we have found 
that the non-hydrolyzable ATP analog, ATPγS, mimicked SAH by triggering high-
amplitude endfoot Ca2+ events and causing inversion of NVC brain slices from control 
animals (Fig. 4).  A number of sources could potentially contribute to elevated levels of 
extracellular ATP in brain parenchyma after SAH.  For example, both neurons and 
astrocytes are capable of releasing ATP through vesicular-mediated exocytosis 27, 36. 
However, it is unlikely that vesicular-mediated ATP release is involved in the generation 
of SAH-induced eHACSs, as neither tetrodotoxin nor bafilomycin impacted these events 
(Fig. 5).  Astrocytes, considered to be a main source of extracellular ATP in the brain 12, 
can also release ATP through connexin-based hemi-channels that are enriched in 
perivascular astrocyte 37, 38.  ATP can also be released from astrocytes via lysosomal-
mediated exocytosis 39.  Interestingly, our previous work demonstrated the presence of 
lysosomes within hypertrophic endfeet after SAH that could represent a supply of ATP 11.  
 Extravascular red blood cells (RBCs) represent another potential source of 
elevated purine nucleotides in brain parenchyma after SAH.  ATP is maintained in 
relatively high abundance (> 1 mM) within intact RBCs 40.  In addition, autopsy studies 
of SAH patients and work using experimental SAH models have both demonstrated 
RBCs deposited along the wall of brain parenchymal arterioles following SAH 10, 41.  
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Considering the relatively small volume of the restricted perivascular space between 
astrocyte endfeet and parenchymal arteriolar myocytes, it is conceivable that RBC lysis 
could cause relatively high local levels of ATP.  However, the appearance of eHACSs 
within 24 hrs following the injection of whole blood into the subarachnoid space 11 does 
not readily fit with the reported time course (3-7 days) for the lysis of RBCs in CSF after 
SAH 42, 43.  Thus, further study will be required to determine the identity and source of 
P2Y receptor ligands involved in the generation of SAH-induced eHACSs. 
 In summary, a growing body of evidence indicates that pathological changes in 
astrocyte Ca2+ signaling occur during disease states such as Alzheimer’s disease, epilepsy 
and SAH 10, 11, 16, 17, 44.  Further, astrocyte Ca2+ signaling profoundly impacts cerebral 
blood flow regulation, including NVC 8, 45, 46.  Here, we expand upon this knowledge by 
identifying a causal link between the activity of Gq-coupled P2Y receptors and the 
emergence of SAH-induced eHACSs and the inversion of NVC.  Our observations are 
consistent with previous reports of P2Y receptor-mediated disruption of astrocyte Ca2+ 
signaling and impaired NVC in mouse models of Alzheimer’s disease 16, 17. Moving 
forward, targeting purinergic signaling in astrocytes may improve cortical blood flow in 
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Figure 3-1.  Inhibition of purinergic signaling with suramin selectively blocks SAH-
induced eHACSs 
(A) Images of control and SAH parenchymal arterioles with overlapping pseudocolor-
mapped fluorescent Ca2+ levels in surrounding astrocyte endfeet obtained using 
simultaneous IR-DIC and 2 photon microscopy (top).  Red-dashed lines depict arteriolar 
lumen.  Scale bar is 10 µm.  Traces demonstrating spontaneous fluctuations in intra-
cellular Ca2+ (i.e. spontaneous Ca2+ events) recorded within the regions corresponding to 
the black boxes in the above images before and after treatment with suramin (bottom).  
The moments in the trace directly beneath the arrows are depicted in the frames above.  
These frames capture peak Ca2+ levels during a typical “control-like” event (<500 nM, 
left) and during an eHACS (≥500 nM, right)  (B) Distribution of all spontaneous Ca2+ 
event amplitudes recorded in brain slices from control and SAH model animals before 
and after treatment with suramin.  Note that eHACSs (red dots, peaks ≥500 nM) are 
almost completely abolished in SAH brain slices treated with suramin.  (C) Summary pie 
chart indicating the incidence of endfeet with eHACSs before and after treatment with 
suramin.  These data only represent endfeet in brain slices from SAH animals.  eHACSs 
were not observed in brain slices from control animals.  (D) Summary data showing the 
effect of suramin on the mean amplitudes of all spontaneous endfoot Ca2+ events in brain 







Figure 3-2.  Blocking eHACSs restores vasodilatory NVC after SAH 
(A) Representative traces showing EFS-induced elevation of endfoot Ca2+ (black lines) 
and subsequent changes in arteriolar diameter (gray lines).  (B) Summary scatter plot 
demonstrating EFS-evoked changes in arteriolar diameter before (black triangles) and 
after (gray triangles) treatment with suramin.  Two-tailed paired t test, **p < 0.01.  (C) 
Summary data showing EFS-evoked changes in endfoot Ca2+ in SAH brain slices before 







Figure 3-3.  P2Y receptors mediate SAH-induced eHACSs 
(A) Representative trace depicting spontaneous Ca2+ activity recorded from a SAH brain 
slice before and after treatment with, α,β-meATP, an ATP analogue that rapidly 
desensitizes P2X receptors.  (B) Distribution of all spontaneous Ca2+ event amplitudes 
recorded in brain slices from SAH animals before and after treatment with α,β-meATP.  
eHACSs (black dots) were still present following desensitization of P2X receptors.  
Horizontal black lines indicate the mean amplitudes of all events.  (C) Summary data 
showing the frequency of endfoot Ca2+ events in the presence or absence of α,β-meATP.  
(D) Representative trace of spontaneous Ca2+ activity recorded from a SAH brain slice 
before and after treatment with a P2Y inhibitor cocktail containing selective P2Y1 (MRS 
2179, 30 µM), P2Y2 (AR-C 118925XX, 10 µM), P2Y6 (MRS 2578, 30 µM), and P2Y11 
(NF 340, 30 µM) antagonists.  (E) Distribution of all spontaneous Ca2+ event amplitudes 
recorded from SAH animals before and after treatment with the P2Y inhibitor cocktail.  
Note that the P2Y inhibitor cocktail selectively abolished eHACSs (black dots).  
Horizontal black lines indicate the mean amplitudes of all events.  Two-tailed paired t 
test, **p < 0.01. (F) Summary data showing the frequency of spontaneous endfoot Ca2+ 








Figure 3-4.  Activation of P2Y receptors in brain slices from control animals mimics 
SAH 
(A) Representative trace showing the effect of ATPγS, a non-hydrolyzable ATP analog, 
on spontaneous Ca2+ activity in a brain slice obtained from a healthy control animal.  In 
these experiments, α,β-meATP was included in the superfusate to desensitize P2X 
receptors.  (B) Distribution of all spontaneous Ca2+ event amplitudes recorded in brain 
slices from control animals before and after treatment with ATPγS.  Note that events 
mimicking SAH-induced eHACSs (black dots, peak Ca2+ ≥500 nM) emerged following 
treatment with ATPγS.  Horizontal black lines indicate the mean amplitudes of all events.  
Two-tailed paired t test, n.s. p = 0.05. (C) Summary data showing the frequency of 
endfoot Ca2+ events in the presence or absence of ATPγS.  Two-tailed paired t test, **p < 
0.01.  (D) Summary scatter plot demonstrating EFS-evoked changes in arteriolar 
diameter in brain slices from healthy control animals before and after treatment with 
ATPγS.  Two-tailed paired t test, *p < 0.05.  (E) Summary data showing EFS-evoked 
changes in endfoot Ca2+ before and after treatment with ATPγS.  For studies examining 








Figure 3-5.  Local neurotransmission is not involved in the generation of eHACSs 
after SAH 
(A) Representative trace of spontaneous Ca2+ activity recorded from a SAH brain slice 
before and after treatment with tetrodotoxin (TTX), a fast Na+ channel inhibitor that 
blocks neuronal action potentials.  (B) Distribution of all spontaneous Ca2+ event 
amplitudes recorded in SAH brain slices before and after treatment with TTX.  Note that 
eHACSs (black dots, peak Ca2+ ≥500 nM) are still present following treatment with TTX.  
Horizontal black lines indicate the mean amplitudes of all events.  (C) Summary data 
showing the frequency of endfoot Ca2+ events in the presence or absence of TTX.  (D) 
Representative traces of spontaneous Ca2+ activity recorded from SAH brain slices from 
either the vehicle-treated time control (left), or bafilomycin A1-treated (right) groups.  
Bafilomycin A1 depletes vesicles of neurotransmitter by inhibiting the vacuolar H+-
ATPase.  (E) Distribution of all spontaneous Ca2+ event amplitudes recorded in SAH 
brain slices from the vehicle-treated time control (- bafilomycin), or bafilomycin A1-
treated groups.  Note eHACSs were not abolished in bafilomycin-treated SAH brain 
slices.  (F) Summary data showing the frequency of endfoot Ca2+ events in vehicle-
treated time control, or bafilomycin A1-treated SAH brain slices.  (G) Summary data 
showing EFS-evoked changes in endfoot Ca2+ recorded from vehicle-treated time control, 
or bafilomycin A1-treated SAH brain slices. Note EFS failed to elevate endfoot Ca2+ in 




Chapter 4: Discussion and Future Directions 
The studies included in this dissertation were designed to address two specific 
aims: (1) to determine whether altered astrocyte Ca2+ signaling, in the form of eHACSs, 
is causally linked to the inversion of neurovascular coupling after SAH and (2) to 
elucidate the cellular basis underlying the generation of eHACSs.  Our data provide 
substantial evidence that SAH-induced eHACSs cause a pathological shift in 
neurovascular coupling from vasodilation to vasoconstriction.  Both phenomena, 
eHACSs and inversion of neurovascular coupling, followed a similar time-dependent 
pattern of development.  Further, depleting ER Ca2+ stores or selectively blocking 
eHACSs restored vasodilatory responses in SAH brain slices. Together, these data 
indicate that eHACSs drive inversion of neurovascular coupling after SAH.  Moreover, 
our results identify perivascular astrocytes as a contributing element to the parenchymal 
arteriolar dysfunction and impaired cerebral hemodynamics commonly observed 
following aneurysmal SAH.   
Our data provide evidence that purinergic signaling via Gq-coupled P2Y receptors 
underlies the generation of eHACSs after SAH.  Treating SAH brain slices with the 
broad-spectrum purinergic receptor antagonist, suramin, selectively blocked eHACSs and 
restored vasodilatory neurovascular coupling.  The fact that a purinergic signaling 
pathway triggers a pathological change in astrocyte Ca2+ signaling after SAH is not 
surprising.  Extracellular purine nucleotides, such as ATP, are commonly elevated in the 
brain following injury (Franke et al., 2012).  Kasseckert et al. (2013) measured a 400-fold 
increase in the concentration of ATP in the cerebrospinal fluid (CSF) of SAH patients 
115 
 
compared to non-SAH controls.  Importantly, the investigators found that exposing 
cultured human astrocytes to the bloody CSF triggered a steep elevation of intra-cellular 
Ca2+ that was prevented by either suramin, or the IP3R antagonist, xestospongin D.  In the 
live rodent, evidence suggests that arterial pulsation drives the flow of CSF into the brain, 
alongside parenchymal arterioles in between astrocyte endfeet and vascular smooth 
muscle (Iliff et al., 2012; Iliff et al., 2013).  This flow pattern would be expected to 
deliver CSF with elevated ATP levels directly into the perivascular space where it could 
alter endfoot Ca2+ dynamics leading to the emergence of eHACSs.   
The above description details one way in which SAH could trigger P2Y receptor-
mediated eHACSs.  However, there are unresolved issues that argue against this 
possibility.  Mainly, in the acute brain slice preparation the flow of CSF has typically 
been stopped for hours before imaging.  Even if ATP levels within the perivascular space 
were elevated at the time the animal was euthanized, ectonucleotidases would likely 
degrade ATP prior to the start of the experiment.  Under physiologic conditions, the 
concentration of extracellular purine nucleotides is regulated by the activity of 
ectonucleoside triphosphate diphosphohydrolases (E-NTPDases).  Astrocytes express 
several members of the E-NTPDase family, with E-NTPDase 2, being the enzyme most 
responsible for ATPase activity (Wink et al., 2006).  Astrocytes also express ecto-5’-
nucleotidase/CD73 allowing them to convert AMP to adenosine (Wink et al., 2003).  
Thus, the full compliment of enzymes expressed by astrocytes would allow them to fully 
degrade ATP trapped within the perivascular space after SAH.  It is important to mention 
here that blood vessels also express E-NTPDases, with E-NTPDase 1 being the 
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predominant enzyme in the brain vasculature (Braun et al., 2000).  Thus, CSF-derived 
ATP seems unlikely to trigger eHACSs in the ex vivo brain slice preparation.    
The multiple reports linking SAH to increased levels of ATP in the CSF have 
suggested that lysed erythrocytes (i.e., red blood cells) are the source of ATP after SAH 
(Macdonald et al., 2001; Yin et al., 2002; Kasseckert et al., 2013).  Given the flow of 
CSF into the brain parenchyma, one would expect extravasated red blood cells to invade 
the brain cortex alongside parenchymal arterioles. In fact, the accumulation of 
extravascular red blood cells in human SAH patients was already described over 50 years 
ago (Crompton, 1964).  Using the double injection cisterna magna SAH model, Koide et 
al. (2012) observed red blood cells adjacent to the parenchymal arteriolar wall, up to 1 
mm from the cortical surface within 10 min of SAH.  Extravascular red blood cells were 
also observed along parenchymal arterioles up to 7 d post-SAH using the acute brain slice 
preparation (Pappas et al., 2015).  It could be argued that the slow and gradual breakdown 
of perivascular red blood cells after SAH leads to a localized elevation of ATP 
independent of the ATP levels in circulating CSF.  Thus, the presence extravascular 
debris may be linked to the emergence of P2Y receptor-mediated eHACSs after SAH.  
Careful studies must be designed to determine whether breakdown of extravascular red 
blood cells generates SAH-induced eHACSs.  A simple first step would be to inject a 
comparable volume of hemolysate into the cisterna magna of anesthetized animals and 
determine whether their brain slices exhibit eHACSs or inversion of neurovascular 
coupling at 2 d post-SAH.  Lysing the red blood cells before delivery into the 
subarachnoid space, would remove the possibility of the cells accumulating along the 
arterioles and gradually releasing their contents into the extracellular milieu.  Although 
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the injected hemolysate would contain high levels of ATP, endogenous ectonucleotidases 
would be expected to degrade the nucleotides relatively quickly. 
   Another possibility is that reactive gliosis is involved in the release of 
extracellular purine nucleotides after SAH.  Inflammatory perturbations to the CNS, 
including SAH, cause nearby microglia to shift from a dormant state to an activated state 
(Murakami et al., 2011; Plog et al., 2014).  In a recent study, Pascual et al. (2012) 
demonstrated that the activation of brain microglia resulted in the release of ATP onto 
nearby astrocytes.  Importantly, the resultant activation of astrocyte P2Y1 receptors 
triggered additional ATP release from the astrocytes, thereby causing an amplification of 
the purinergic signal.  In addition to stimulating the release of gliotransmitters, activation 
of P2Y1 receptors has been linked to the development of reactive astrogliosis (Franke et 
al., 2001).  There is strong evidence, such as increased expression of glial fibrillary acidic 
protein (GFAP) and S100β, that reactive astrogliosis occurs following SAH (Yokota et 
al., 1994; Murakami et al., 2011).  Presently, we demonstrate a hypertrophic morphology 
of astrocyte endfeet, a clear indication of reactive astrogliosis, in tissue obtained from 2 d 
SAH animals (see Fig. 2-5).  Our time course data show a gradual emergence of endfeet 
exhibiting eHACSs, reaching a peak at 2 d post-SAH, and then slowly declining at later 
time-points (see Fig. 2-1).  The prevailing thought is that the inflammatory component to 
reactive gliosis occurs early following injury (between 0 and 7 d post-insult) and 
subsequently shifts to a phase of cell proliferation and tissue remodeling (Burda and 
Sofroniew, 2014).  Interestingly, the time course in which the inflammatory response is 
suggested to occur appears to coincide with the emergence of eHACSs and development 
of inversion of neurovascular coupling.  Future studies will be necessary to determine the 
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relationship between these phenomena.  For example, one could use 
immunohistochemistry to determine if SAH-induced activated microglia are in close 
enough proximity to initiate ATP release from perivascular astrocytes.  To date, the vast 
majority of work suggests that astrocyte ATP release mechanisms involve either: (1) 
Ca2+-dependent exocytosis of ATP-containing vesicles (Montana et al., 2006; Bowser 
and Khakh, 2007), (2) ATP efflux through plasmalemmal hemichannels formed by 
connexins and pannexins (Kang et al., 2008), or (3) ATP release via lysosomes (Zhang et 
al., 2007).  Functional studies targeting the above mechanisms could also be used to 
determine whether eHACSs after SAH are the result of a paracrine/autocrine astrocyte 
purinergic signaling pathway. 
Our data demonstrate that suramin selectively blocked eHACSs and restored 
vasodilatory neurovascular coupling after SAH.  Although suramin is recognized as a 
broad-spectrum purinergic (P2) receptor antagonist (Ralevic and Burnstock, 1998), it has 
also been suggested to have many off-target effects including: disruption of growth factor 
receptor signaling (Coffey et al., 1987), uncoupling of G-protein coupled receptors 
(Beindl et al., 1996), and activation of skeletal muscle ryanodine receptors (Hohenegger 
et al., 1996).  Despite the widespread actions of suramin, the positive effects we observed 
in SAH brain slices are most likely due to block of P2Y receptor signaling.  Most 
importantly, we observed a similar block of SAH-induced eHACSs in brain slices treated 
with a cocktail of inhibitors targeting Gq-coupled P2Y receptors (Fig. 3-3).  These data 
argue against potential off-target effects, such as disruption of growth factor receptor 
signaling.  Currently, there is a lack of evidence supporting functional expression of 
ryanodine receptors (i.e., ER Ca2+ release channels) in astrocytes in situ (Straub et al., 
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2006).  If suramin were activating astrocyte ryanodine receptors, then one would predict 
that suramin would cause an increased amplitude and frequency of endfoot Ca2+ events.  
Instead, we observed a selective blockade of SAH-induced eHACSs and no change in 
Ca2+ event frequency in control or SAH brain slices following treatment with suramin 
(Fig. 3-1).  Our results also argue against an uncoupling of G-protein coupled receptors.  
The endfoot Ca2+ transients evoked by EFS are sensitive to phospholipase C inhibition 
indicating that Gq-coupled receptors mediate neuronal activity-dependent elevation of 
endfoot Ca2+ (Straub et al., 2006).  We observed no change in the amplitude of the EFS-
evoked endfoot Ca2+ transients in brain slices treated with suramin (Fig. 3-2).  Further, 
the vasoconstrictor, U46619, is a Gq-coupled receptor agonist.  If suramin were 
uncoupling G-protein coupled receptors, then one would predict that suramin would 
abolish arteriolar tone.  However, we observed no change in parenchymal arteriolar 
diameter following treatment with suramin.  Thus, despite suramin’s potential off-target 
effects, the most likely explanation for our results is that suramin is disrupting SAH-
induced eHACSs by blocking astrocyte P2Y receptors.    
Suramin is a well-tolerated FDA-approved drug that has been used previously to 
treat high-grade glioma (Grossman et al., 2001).  This is significant as it identifies a 
signaling pathway that could be targeted therapeutically in the management of SAH 
patients.  Current therapeutic options are limited and often have poor efficacy.  
Experimental evidence using a canine SAH model has already provided evidence that in 
vivo treatment with suramin reduces the severity of SAH-induced vasospasm; although 
the investigators claim the effects were due to inhibition of tyrosine kinase activity 
(Kimura et al., 2002).  Future studies will be necessary to determine (1) if inversion of 
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neurovascular coupling occurs in SAH animals in vivo, and (2) if suramin can restore or 
improve vasodilatory neurovascular coupling after SAH.   
Our data provide strong evidence that SAH-induced eHACSs are mediated by the 
activity of Gq-coupled P2Y receptors.  Astrocytes express most P2Y receptor subtypes 
and immunohistochemical examination has already revealed expression of the Gq-
coupled receptors P2Y1, P2Y2 and P2Y4 on perivascular endfeet (Franke et al., 2012; 
Simard et al., 2013).  There have been no studies examining the localization of other 
astrocyte Gq-coupled P2Y receptors in relation to the intra-cerebral vasculature.  It is 
possible that multiple P2Y receptor subtypes are responsible for the generation of 
eHACSs after SAH.  P2Y receptors can exist as homodimers or heterodimers with other 
P2 receptors, or P1 (i.e., adenosine) receptors (Tonazzini et al., 2008; Koles et al., 2011).  
Further, if extracellular purine and/or pyrimidine nucleotides are driving the generation of 
eHACSs after SAH, then it stands to reason that one P2Y receptor could be involved in 
triggering a Ca2+ event in response to ATP, while another receptor responds to ATP’s 
degradation product, ADP.  Accordingly, the same would be expected for the pyrimidines 
UTP and UDP.  Thus, it seems that a broad-spectrum purinergic receptor antagonist, such 
as suramin, would be the most useful approach to block P2Y receptor-mediated eHACSs 
after SAH.  Future studies using a combination of qPCR/western blotting and 
immunohistochemistry could be useful to determine if SAH leads to an increased 
expression of Gq-coupled P2Y receptors in perivascular astrocytes.  This may aid in 
narrowing down the exact mechanism by which extracellular purine and/or pyrimidine 
nucleotides trigger eHACSs. 
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To conclude, the studies presented in this dissertation demonstrate that the 
inversion of neurovascular coupling after SAH is due to a pathological change in 
astrocyte endfoot Ca2+ signaling (i.e., eHACSs).  Our results provide clear evidence that 
perivascular astrocytes play a pivotal role in mediating SAH-induced vascular 
dysfunction.  Importantly, our data indicate a role for extracellular purine and/or 
pyrimidine nucleotides in the generation of eHACSs after SAH.  We report that inhibition 
of Gq-coupled P2Y receptors selectively blocked eHACSs and restored vasodilatory 
neurovascular coupling in brain slices obtained from SAH animals.  Moving forward, it 
will be important to determine the link between SAH and enhanced purinergic signaling.  
Further, it will be necessary to consider the role of perivascular astrocytes in the 
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